Gastro Flashcards

1
Q

What does maltase do?

A

cleaves disaccharide maltose to glucose + glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does sucrose do?

A

cleaves sucrose to fructose and glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what does galactose do?

A

cleaves disaccharide lactose to glucose + galactose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the source/stimulus/actions of gastrin?

A

G cells in antrum of the stomach

Stimulated by:
Distension of stomach, vagus nerves (mediated by gastrin-releasing peptide), luminal peptides/amino acids

Inhibited by:
• low antral pH • somatostatin

↑ HCL= Increases acid secretion by gastric parietal cells, pepsinogen and IF secretion, increases gastric motility, stimulates parietal cell maturation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the source/stimulus/actions of CCK?

A

I cells in upper small intestine

Stimulated by:
Partially digested proteins and triglycerides

↑ secretion of enzyme-rich fluid from pancreas, contraction of gallbladder and relaxation of sphincter of Oddi, ↓ gastric emptying, trophic effect on pancreatic acinar cells, induces satiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the source/stimulus/actions of secretin?

A

S cells in upper small intestine

Stimulated by:
Acidic chyme, fatty acids

↑ secretion of bicarbonate-rich fluid from pancreas and hepatic duct cells, ↓ gastric acid secretion, trophic effect on pancreatic acinar cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the source/stimulus/action of VIP?

A

Small intestine / pancreas

Stimulated by:
Neural

Stimulates secretion by pancreas and intestines, inhibits acid and pepsinogen secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the source/stimulus/action of somatostatin?

A

D cells in the pancreas & stomach

Stimulated by:
Fat, bile salts and glucose in the intestinal lumen

↓ acid and pepsin secretion, ↓ gastrin secretion, ↓ pancreatic enzyme secretion, ↓ insulin and glucagon secretion
inhibits trophic effects of gastrin, stimulates gastric mucous production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the 3 principle mediators of acid secretion?

A

Principle mediators of acid secretion
• Gastrin
• Vagal stimulation
• Histamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are 4 factors that will increase acid secretion?

A

Factors increasing acid secretion
• Gastrinoma
• Small bowel resection (removal of inhibition)
• Systemic mastocytosis (elevated histamine levels)
• Basophilia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are 2 factors that will decrease acid secretion?

A

Factors decreasing acid secretion
• Drugs: H2-antagonists, PPIs
• Hormones: secretin, VIP, GIP, CCK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a pharyngeal pouch?
–where is this situated anatomically?
-who is this most commonly found in?

A

Pharyngeal Pouch is a posteromedial diverticulum or herniation through Killian’s dehiscence.
Killian’s dehiscence is a triangular area in the wall of the pharynx between the thyropharyngeus and cricopharyngeus muscles.
It is more common in older patients and is 5 times more common in men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are 5 features of pharyngeal pouch?

A

Features
• Dysphagia
• Regurgitation
• Aspiration
• Neck swelling which gurgles on palpation
• Halitosis (noticeably unpleasant odors exhaled in breathing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is travellers diarrhoea?

A

Travellers’ diarrhea may be defined as at least 3 loose to watery stools in 24 hours with or without one or more of abdominal cramps, fever, nausea, vomiting or blood in the stool.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the most common cause of travellers diarrhoea?
-what are the clinical features?
-what is the incubation period?

A

The most common cause is Escherichia coli
Watery stools
Abdominal cramps and nausea
12-48hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is ‘acute food poisoning’? and what are the typical causes?

A

Another pattern of illness is ‘acute food poisoning’. This describes the sudden onset of nausea, vomiting and diarrhea after the ingestion of a toxin. Acute food poisoning is typically caused by Staphylococcus aureus, Bacillus cereus or Clostridium perfringens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

which pathogen causes Prolonged, non-bloody diarrhea?
what should be found in stool?
what is the treatment?

A

Giardiasis
Diagnosis – look for cysts or parasites in stool
Treatment – metronidazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

which pathogen causes Profuse, watery diarrhea?
what is this commonly assoc with?

A

Cholera
toxin mediated disease often associated with outbreaks – refugee camps
uncommon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

which pathogen causes bloody diarrhoea?
-what are other features?
-what is the incubation period?

A

Shigella
Vomiting and abdominal pain
48-72 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

which pathogen causes severe vomiting?
-what is the incubation period?
-what foods are assoc?

A

Staph. Aureus
short incubation
Foods that have been frequently implicated in SFD are meat and meat products, poultry and egg products, milk and dairy products, salads, bakery products, especially cream-filled pastries and cakes, and sandwich fillings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

which pathogen causes a flu-like prodrome
followed by crampy abdominal pains
fever and diarrhoea which may be bloody?
-what syndrome is assoc with this?
-is this common?
-what is the incubation period?

A

Campylobacter
complications included guillian barre
most common cause in the UK
48-72 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

which pathogen causes 2 types illness:
vomiting within 6 hours
diarrhoeal illness occurring after 6 hours
-what food assoc exists?
-what is the incubation period?

A

Bacillus cereus
-Bacillus cereus infection most commonly results from reheated rice
-1-6hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

which pathogen causes Gradual onset bloody diarrhea abdominal pain and tenderness may last for several weeks?
-what seen on stool microscopy?
-what is treatment with?
-what can this disease also cause?

A

Amoebiasis
-stool microscopy may show trophozoites if examined within 15 minutes or kept warm (known as a ‘hot stool’)
-Treatment is with metronidazole
-Treatment for invasive amoebiasis should be followed by a luminal amoebicide to eradicate the cystic stage which is resistant to metronidazole and tinidazole (which are used against the invasive stage).

-Amoebiasis also causes liver and colonic abscesses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

describe the liver abscesses caused by amoebiasis?
-where abouts is this found?
-what 2 clinical features are seen?
-what investigations can be done?

A

usually a single mass in the right lobe (may be multiple). The contents are often described as ‘anchovy sauce’
features: fever, RUQ pain
serology is positive in > 90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what type of organism is c. diff?
-what syndrome does this cause?

A

gram +ve rod
It produces an exotoxin which causes intestinal damage leading to a syndrome called pseudomembranous colitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what is the cause of c. diff?

A

Clindamycin is historically associated with causing Clostridium difficile but the aetiology has evolved significantly over the past 10 years. Second and third generation cephalosporins (e.g ciprofloxacin) are now the leading cause.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

describe the clinical features of c. diff?

A

Features:
• Diarrhea
• Abdominal pain
• If severe, toxic dilatation
• Sometimes seen in nosocomial outbreaks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what is the diagnosis of c. diff?

A

Diagnosis is made by detecting Clostridium difficile TOXIN (CDT) in the stool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what is included in the management of c. diff?

A

Management:
• ORAL metronidazole for 10-14 days
• If severe or not responding to metronidazole then ORAL vancomycin may be used.
• For life-threatening infections a combination of oral vancomycin and intravenous metronidazole
should be used

fidaxomicin may also be used for patients who are not responding , particularly those with multiple co-morbidities

Other therapies
bezlotoxumab is a monoclonal antibody which targets Clostridium difficile toxin B - it is not in widespread use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

what is small bowel overgrowth syndrome?
-what are the clinical features?

A

Small bowel bacterial overgrowth syndrome (SBBOS) is a disorder characterised by excessive amounts of bacteria in the small bowel resulting in gastrointestinal symptoms.

It should be noted that many of the features overlap with irritable bowel syndrome:

chronic diarrhoea
bloating, flatulence
abdominal pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

what are the risk factors for SBOS?

A

Risk factors for SBBOS
-neonates with congenital gastrointestinal abnormalities
-scleroderma
-diabetes mellitus

Important association: Systemic sclerosis, diverticulae and blind loop.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

what are the investigations for SBOS?

A

Diagnosis
-hydrogen breath test
-small bowel aspiration and culture: this is used less often as invasive and results are often difficult to reproduce
clinicians may sometimes give a course of antibiotics as a diagnostic trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

what exotoxin does diphtheria release?
-what does this cause?

A

Diphtheria toxin commonly causes a ‘diphtheric membrane’ on tonsils caused by necrotic mucosal cells.
Systemic distribution may produce necrosis of myocardial, neural and renal tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

what exotoxin does e coli release?
-what does this cause?

A

Staph. aureus exotoxins lead to acute gastroenteritis, toxic shock syndrome and Staphylococcal scalded
skin syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

what is the treatment for SBOS?

A

Management

correction of underlying disorder
antibiotic therapy: rifaximin is now the treatment of choice due to relatively low resistance. Co-amoxiclav or metronidazole are also effective in the majority of patients.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What exotoxin leads to lockjaw?

A

Lockjaw is caused by Clostridium tetani neurotoxin (tetanospasmin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

what does cholera toxin cause?

A

Cholera toxin causes activation of adenylate cyclase leading to ↑ in cAMP levels, which in turn leads to ↑ chloride secretion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

describe the acute treatment of eosophageal varices
-what should be done ideally prior to endoscopy?
-what agents can be used - how do these work?
-what can help to decrease mortality in patients with liver cirrhosis?
-can be used in uncontrolled haemorrhage?
-if all else fails what can be used?

A

Acute treatment of variceal hemorrhage
• ABC: patients should ideally be resuscitated prior to endoscopy
• Correct clotting: FFP, vitamin K
• Vasoactive agents: terlipressin is currently the only licensed vasoactive agent. It has been shown to be of benefit in initial hemostasis and preventing rebleeding. It acts by Constriction of the splanchnic vessels (contraindicated in
IHD, use Octreotide as alternative)
• Prophylactic antibiotics have been shown in multiple meta-analyses to ↓ mortality in patients
with liver cirrhosis
• Endoscopy: endoscopic variceal band ligation is superior to endoscopic sclerotherapy
• Sengstaken-blakemore tube if uncontrolled hemorrhage (in urgent setting when endoscopy is not ready)
• Transjugular intrahepatic portosystemic shunt (TIPSS) if above measures fail

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What is used and done in the prophylaxis of variceal haemorrhage?

A

Prophylaxis of variceal hemorrhage
• Propranolol: ↓ rebleeding and mortality compared to placebo
• Endoscopic variceal band ligation (EVL) is superior to endoscopic sclerotherapy. It should be
performed at two-weekly intervals until all varices have been eradicated. Proton pump inhibitor cover is given to prevent EVL-induced ulceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Describe the pathology of barretts oesophagus?
-what does this increase the risk of?
-how can is barretts oesophagus classed?

A

Barrett’s Esophagus refers to the metaplasia of the lower esophageal mucosa, with the usual squamous epithelium being replaced by columnar epithelium. There is ↑ risk of esophageal adenocarcinoma, estimated at 50-100 folds.
Barrett’s can be subdivided into short (<3cm) and long (>3cm). The length of the affected segment correlates strongly with the chances of identifying metaplasia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

describe the histological features of the columnar epithelium in barretts oesophagus?

A

Histological features: the columnar epithelium may resemble that of either the cardiac region of the stomach or that of the small intestine (e.g. with goblet cells, brush border)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

describe the management of barretts oesophagus?

A

Management
• Endoscopic surveillance with biopsies
-for patients with metaplasia (but not dysplasia) endoscopy is recommended every 3-5 years

If dysplasia of any grade is identified endoscopic intervention is offered. Options include:
endoscopic mucosal resection
radiofrequency ablation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

what are indications for OGD in GORD?

A

Indications for upper GI endoscopy:
• Age > 55 years
• Symptoms > 4 weeks or persistent symptoms despite treatment
• Dysphagia
• Relapsing symptoms
• Weight loss

Usually there is poor correlation between symptoms and endoscopy appearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

what is the gold standard investigation in GORD?

A

24hr esophageal pH monitoring is gold standard investigation in GORD

If endoscopy is negative consider 24-hr oesophageal pH monitoring (the gold standard test for diagnosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Pain on swallowing (odynophagia) is a typical of esophageal candidiasis - what is this a well documented complication of?

A

inhaled steroid therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Oesophageal Ca is a cause of dysphagia - what is this commonly assoc with? what may past history include?

A

-associated with weight loss, anorexia or vomiting during eating
-Past history may include Barrett’s esophagus, GERD, excessive smoking or alcohol use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Oesophagitis is a cause of dysphagia - what clinical features is assoc with this?

A

-May be history of heartburn
-Odynophagia but no weight loss and systemically well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

oesophageal candidiasis is a cause of dysphagia - what may there be a history of?

A

There may be a history of HIV or other risk factors such as steroid inhaler use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Achalasia is a cause of dysphagia - what are three clinical features assoc. with this?

A

-Dysphagia of both liquids and solids from the start
-Heartburn
-Regurgitation of food - may lead to cough, aspiration pneumonia etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Pharyngeal pouch is a cause of dysphagia:
-who is this more common in?
-what are the clinical features?

A

More common in older men
-Represents a posteromedial herniation between thyropharyngeus and cricopharyngeus muscles
-Usually not seen but if large then a midline lump in the neck that gurgles on palpation
-Typical symptoms are dysphagia, regurgitation, aspiration and chronic cough. Halitosis may occasionally be seen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Systemic sclerosis is a cause of dysphagia:
-what are the other features of CREST?

A

Other features of CREST syndrome may be present, namely Calcinosis, Raynaud’s phenomenon, Esophageal dysmotility, Sclerodactyly, Telangiectasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Myaesthenia gravis is a cause of dysphagia
-what are other clinical features that may be seen

A

Other symptoms may include extraocular muscle weakness or ptosis Dysphagia with liquids as well as solids
Globus hystericus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Globus hystericus is a cause of dysphagia:
-what other clinical features may be seen?

A

May be history of anxiety Symptoms are often intermittent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Achalasia is a cause of dysphagia:
-what is this?
-when does this normally present?

A

Failure of esophageal peristalsis and of relaxation of lower esophageal sphincter (LOS) due to degenerative loss of ganglia from Auerbach’s plexus i.e. LOS contracted, esophagus above dilated. Achalasia typically presents in middle-age and is more common in women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Name 6 clinical features of achalasia?

A

• Dysphagia of BOTH liquids and solids
• Typically variation in severity of symptoms
• Heartburn
• Regurgitation of food - may lead to cough, aspiration pneumonia etc
• Malignant change in small number of patients
• 7% ↑ in risk of squamous cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

what is the gold standad for achalasia?
- what other investigations would be relevant?

A

The gold standard test for achalasia is esophageal manometry
• Barium swallow shows grossly expanded esophagus, fluid level
• CXR: wide mediastinum, fluid leve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

what manometry finding would be found in achalasia?

A

Loss of peristalsis in distal esophagus, failure of LOS to relax during swallowing and (i.e ↑ residual relaxing pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

what manometry finding would be found in scleroderma?

A

Loss of peristalsis in distal esophagus BUT ↓ resting LOS pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

describe the treatment of achalasia?

A

• Intra-sphincteric injection of botulinum toxin
• Heller cardiomyotomy
• Balloon dilation
• Drug therapy has a role but is limited
by side-effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

what is Boerhaave’s syndrome?

A

Complete transmural (full-thickness) laceration or perforation of the esophagus, distinct from Mallory-Weiss syndrome, a nontransmural esophageal tear also associated with vomiting.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Boerhaave’s syndrome:
-where is perforation almost always found?
-what would be found on pleural fluid aspirate?
-more common in men or women?
-what ages does this effect?
-what other clinical features may be found?

A

• Perforation is almost always on Left side of Lower esophagus.
• Gastric contents enter the mediastinum and pleural cavity, if one were to perform a pleural fluid
aspirate; one is likely to aspirate gastric contents!
• ♂ > ♀ and typically between 50-70 years old
• Other clinical features that may suggest the diagnosis include odynophagia and surgical
emphysema in the neck

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

What are the different causes for boerhaaves syndrome?

A

• Vomiting (against a closed glottis) in eating disorders such as bulimia
• Rarely: Extremely forceful coughing - Obstruction by food

Iatrogenic perforation, accounts for 85-90% of cases of esophageal rupture, typically as a complication of an endoscopic procedure, feeding tube, or unrelated surgery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

what are the investigation findings in boerhaaves syndrome?

A

• Radiographs show mediastinal gas, effusion, and later pneumothorax.
Esophagram is used to confirm leak, first with water-soluble contrast, then barium if no leak demonstrated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

what is the management for boerhaaves syndrome?

A

Early operation after appropriate resuscitation offers the best chance of survival.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

what drugs can causes dyspepsia?

A

Causes
• NSAIDs
• Bisphosphonates • Steroids
The following drugs may cause reflux by reducing lower esophageal sphincter (LOS) pressure
• Calcium channel blockers*
• Nitrates*
• Theophyllines
*calcium channel blockers and nitrates are occasionally used in the management of achalasia, itself a cause of dyspepsia, because of their effect on the LOS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

What are 7 ‘alarm’ signs in dyspepsia?

A

• Chronic gastrointestinal bleeding
• Progressive unintentional weight loss
• Progressive difficulty swallowing
• Persistent vomiting
• Iron deficiency anemia
• Epigastric mass
• Suspicious barium meal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

when do patients need an urgent referral with dyspepsia?

A

Urgent referral (within 2 weeks) is indicated for patients with any alarm signs irrespective of age.

Routine endoscopic investigation of patients of any age, presenting with dyspepsia and without alarm signs is not necessary, however patients aged 55 years and over should be referred urgently for endoscopy if dyspepsia symptoms are:
• Recent in onset rather than recurrent and
• Unexplained (e.g. New symptoms which cannot be explained by precipitants such as NSAIDs)
and
• Persistent: continuing beyond a period that would normally be associated with self-limiting
problems (e.g. Up to four to six weeks, depending on the severity of signs and symptoms)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

How do you manage patients who have dyspepsia but do not meet referral criteria - ‘undiagnosed dyspepsia’?

A

This can be summarised at a step-wise approach
• Review medications for possible causes of dyspepsia
• Lifestyle advice
• Trial of full-dose PPI for one month*
• ‘Test and treat’ using carbon-13 urea breath test
*it is unclear from studies whether a trial of a PPI or a ‘test and treat’ should be used first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

what kind of bacteria is h. pylori?

A

Helicobacter pylori is a Gram negative bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

what diseases is h pylori associated with?

A

Associations
• Peptic ulcer disease (95% of duodenal ulcers, 75% of gastric ulcers)
• Gastric cancer
• B cell lymphoma of MALT tissue (eradication of H pylori 80% causes regression)
• Atrophic gastritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Is there a role for eradicating H pylori in GORD?

A

The role of H pylori in Gastresophageal reflux disease (GERD) is unclear - there is currently no role of eradication of H pylori in GERD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

what are the 6 different tests that exist for h. pylori?

A

-Urea breath test
-Rapid urease test (e.g. CLO test)
-Serum antibody
-Culture of gastric biopsy
-Gastric biopsy
-Stool antigen test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

Urea breath test:
-what should be stopped prior to test?
-how does it work?
-what is it used for in addition to diagnosis?
-sensitive?specific?

A

• Patients consume a drink containing carbon isotope 13 (13C) enriched urea
• Urea is broken down by H. pylori urease
• After 30 mins patient exhale into a glass tube
• Mass spectrometry analysis calculates the amount of 13C CO2
• Sensitivity 95-98%, specificity 97-98%
• Used to confirm eradication
• Should not be performed within 4 weeks of treatment with an antibacterial or within 2 weeks of an antisecretory drug (e.g. a proton pump inhibitor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Rapid Urease Test: CLO
-how does this work?
-sensitive/specific?

A

• Biopsy sample is mixed with urea and pH indicator
• Color change if H pylori urease activity
• Sensitivity 90-95%, specificity 95-98%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Serum antibody test for H pylori
-what is the con for this?
-sensitivity/specificity?

A

• Remains positive after eradication
• Sensitivity 85%, specificity 80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Culture of gastric biopsy in h. pylori
-what does this provide information on?
-sensitive/specific?

A

• Provide information on antibiotic sensitivity
• Sensitivity 70%, specificity 100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Gastric biopsy in h. pylori
-what does this provide information on?
-sensitive/specific?

A

• Histological evaluation alone, no culture
• Sensitivity 95-99%, specificity 95-99%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

how sensitive/specific is a stool antigen test in h.pylori

A

• Sensitivity 90%, specificity 95%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

what is peutz-jeghers syndrome?
-how is this inherited?
-what is this characterised by?

A

Peutz-Jeghers syndrome is an autosomal dominant condition characterized by numerous hamartomatous polyps in the gastrointestinal tract.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

what is the mortality of peutz-jeghers syndrome?

A

Around 50% of patients will have died from a gastrointestinal tract cancer by the age of 60 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

How is peutz-jeghers syndrome inherited?
-what does the responsible gene encode?

A

• Autosomal dominant
• Responsible gene encodes serine threonine
kinase LKB1 or STK11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Describe the features of peutz-jeghers syndrome?

A

• Hamartomatous polyps in GI tract (mainly small bowel)
• Pigmented lesions on lips, oral mucosa, face, palms and soles
• classical histological appearance of smooth muscle “arborisation”
• Intestinal obstruction e.g. Intussusception
• Gastrointestinal bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

what is the management of peutz-jeghers syndrome?

A

• Conservative unless complications develop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

what is oesophageal cancer most commonly due to?
-what conditions are associated with this?
-where are the majority of tumours anatomically?

A

Until recent time esophageal cancer was most commonly due to a squamous cell carcinoma but the incidence of adenocarcinoma is rising rapidly. Adenocarcinoma is now (since 2010) the most common type of oesophageal cancer and is more likely to develop in patients with a history of gastro-esophageal reflux disease (GERD) or Barrett’s.
The majority of tumours are in the middle third of the esophagus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

is anything protective against oesophageal ca?

A

Helicobacter pylori may actually be protective against esophageal cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

what are the risk factors for squamous cell carcinoma of the oesophagus?

A

• Smoking
• Alcohol
• Achalasia
• Plummer-vinson syndrome
• Rare: coeliac disease, scleroderma
• Sensetive to radiotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

what are the risk factors for adenocarcinoma of the oesophagus?

A

• GERD
• Barrett’s esophagus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

what cells are seen in gastric adenocarcinoma?

A

signet ring cells

signet ring cells may be seen in gastric cancer. They contain a large vacuole of mucin which displaces the nucleus to one side. Higher numbers of signet ring cells are associated with a worse prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

Gastric Ca
-peak age
-countries affected?
-males or females?

A

pidemiology
• Overall incidence is decreasing, but incidence of tumors arising from the cardia is increasing
• Peak age = 70-80 years
• More common in Japan, China, Finland and Columbia than the west
• More common in ♂s, 2:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

what are 7 associations with gastric ca?

A

• H. pylori infection (although it is protective against esophageal cancer)
• Blood group A: gAstric cAncer
• Gastric adenomatous polyps
• Pernicious anemia
• Smoking
• Diet: salty, spicy, nitrates
• May be negatively associated with duodenal ulcer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

what is the diagnosis of gastric ca?
-what is the staging?

A

• Diagnosis: endoscopy with biopsy
• Staging:
-CT or endoscopic ultrasound - endoscopic ultrasound has recently been shown to be
superior to CT
(CT scanning of the chest abdomen and pelvis is the routine first line staging investigation in most centres.
Laparoscopy to identify occult peritoneal disease
PET CT (particularly for junctional tumours))

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

what are the clinical features of gastric Ca?

A

dyspepsia
nausea and vomiting
anorexia and weight loss
dysphagia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

what are the 3 different types of tumours of the gastro-oesophageal junction?

A

Type 1 True oesophageal cancers and may be associated with Barrett’s oesophagus.

Type 2 Carcinoma of the cardia, arising from cardiac type epithelium
or short segments with intestinal metaplasia at the oesophagogastric junction.

Type 3 Sub cardial cancers that spread across the junction. Involve similar nodal stations to gastric cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

what is the treatment for gastric ca:
-proximally sited disease
-if tumour <5cm OG junction
-type 2 junctional tumours
-lymph nodes
-additional chemo/radio?

A

Proximally sited disease greater than 5-10cm from the OG junction may be treated by sub total gastrectomy

Total gastrectomy if tumour is <5cm from OG junction

For type 2 junctional tumours (extending into oesophagus) oesophagogastrectomy is usual

Endoscopic sub mucosal resection may play a role in early gastric cancer confined to the mucosa and perhaps the sub mucosa (this is debated)

Lymphadenectomy should be performed. A D2 lymphadenectomy is widely advocated by the Japanese, the survival advantages of extended lymphadenectomy have been debated. However, the overall recommendation is that a D2 nodal dissection be undertaken.

Most patients will receive chemotherapy either pre or post operatively.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

colorectal cancer screening:
-why is this done?
-what are the main techniques being evaluated?
-which technique can reduce mortality?
-what is the role of CEA?

A

Screening:
• Most cancers develop from adenomatous polyps therefore a screening program could theoretically ↓ mortality
• Main techniques being evaluated are faecal occult blood (FOB) testing, sigmoidoscopy and colonoscopy

• Fecal occult blood testing is the only method to have been proven to ↓ mortality (by about 20%) in trials. Sensitivity can be ↑ by DNA analysis for the APC gene

• Trials looking at screening using flexible sigmoidoscopy are currently underway

• Carcinoembryonic antigen may be used to monitor for recurrence in patients post- operatively or to assess response to treatment in patients with metastatic disease. The CEA-scan study is a nuclear medicine procedure — that uses a small dose of radioactive isotope to image tumors sometimes invisible to other diagnostic tests. That isotope is guided to tumors via antibody fragments engineered to seek out and attach to any tissue that expresses carcinoembryonic antigen (CEA), a protein found on virtually all colorectal tumors. CEA blood tests attempt to detect this same protein in blood, but often fail to do so, due to lack of
sensitivity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

what are 4 different causes of a positive faecal occult blood test?

A

Causes for a positive fecal occult blood testing are:
• 2-10%: cancer (colorectal cancer, gastric cancer)
• 20-30% adenoma or polyps
• Bleeding peptic ulcer
• Angiodysplasia of the colon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

what is the national screening programme in the UK for colorectal ca?
-who gets it?
-how is this sent?
-how does it work?
-what is the advantage over conventional FOB tests?
-if this is abnormal what happens?

A

-the NHS now has a national screening programme offering screening every 2 years to all men and women aged 60 to 74 years in England, 50 to 74 years in Scotland. Patients aged over 74 years may request screening
-eligible patients are sent Faecal Immunochemical Test (FIT) tests through the post
-a type of faecal occult blood (FOB) test which uses antibodies that specifically recognise human haemoglobin (Hb)
-used to detect, and can quantify, the amount of human blood in a single stool sample
-advantages over conventional FOB tests is that it only detects human haemoglobin, as opposed to animal haemoglobin ingested through diet
-only one faecal sample is needed compared to the 2-3 for conventional FOB tests
-whilst a numerical value is generated, this is not reported to the patient or GP, who will instead be informed if the test is normal or abnormal
-patients with abnormal results are offered a colonoscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

if patients have an abnormal FIT test:
-how many will have a normal exam?
-how many will have polyps?
-how many will have cancer?

A

5 out of 10 patients will have a normal exam
4 out of 10 patients will be found to have polyps which may be removed due to their premalignant potential
1 out of 10 patients will be found to have cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

what is ‘bowel scope screening’?
-who can get this?
-what is this?

A

screening for bowel cancer using sigmoidoscopy is being rolled out as part of the NHS screening program
the aim (other than to detect asymptomatic cancers) is to allow the detection and treatment of polyps, reducing the future risk of colorectal cancer
this is being offered to people who are 55-years-old
NHS patient information leaflets refer to this as ‘bowel scope screening’
patients can self-refer for bowel screening with sigmoidoscopy up to the age of 60, if the offer of routine one-off screening at age 55 had not been taken up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

Describe ‘Dukes Staging’ in colorectal cancer?

A

• The Dukes staging system is widely employed for classifying colorectal cancers and is a useful predictor of survival. Tumour grade and depth of penetration are also important:
• Duke A (Stage I) defines a tumour confined to the bowel wall (i.e. mucosa and submucosa).
• Duke B (Stage II) invades through the muscle wall.
• Duke C (Stage III) involves lymph nodes.
• After this the patient presents with metastatic disease at distant sites (Stage IV).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

what are 5 prognostic indicators post complete resection in colorectal ca?

A

• Poorly differentiated histological type.
• Tumour adherence to adjacent organs.
• Bowel perforation.
• Colonic obstruction at the time of diagnosis.
• Venous invasion by the tumour.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

describe the management of colorectal ca
-what is the main treatment
-when is adjuvant chemo warranted? what other drug can be added and what is its side effect?
-when is adjuvant radiotherapy used?
-when is adjuvant radiotherapy combined with chemo?

A

• Surgical excision of a colonic carcinoma is the main treatment
• Adjuvant chemotherapy (5-fluorouracil and folinic acid) is warranted in high-risk stage II colonic carcinomas and all stage III colonic carcinomas.
• The addition of oxaliplatin has been shown to improve survival in these patients in a large
multicentre trial (MOSAIC study), but the additional drug can cause a severe peripheral
neuropathy.
• Adjuvant radiotherapy is used in rectal carcinomas. This is combined with chemotherapy in
stage II and III rectal carcinomas to reduce the risk of local as well as metastatic relapse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

what are the three types of colon cancer genetically?

A

• Sporadic (95%)
• Hereditary non-polyposis colorectal carcinoma (HNPCC, 5%)
• Familial adenomatous polyposis (FAP, <1%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

what genetic mutations are implicated in sporadic colon ca?

A

Studies have shown that sporadic colon cancer may be due to a series of genetic mutations. For example, more than half of colon cancers show allelic loss of the adenomatous polyposis coli (APC) gene. It is believed a further series of gene abnormalities e.g. activation of the K-ras oncogene, deletion of p53 and DCC tumour suppressor genes lead to invasive carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

HNPCC:
-how is this inherited?
-how many people will develop ca?
-what is the nature of the ca that develops?
-how many gene mutations have been identified?

A

HNPCC, an autosomal dominant condition, is the most common form of inherited colon cancer. Around 90% of patients develop cancers, often of the proximal colon, which are often poorly differentiated and highly aggressive. Currently four gene mutations have been identified (including in the hMLH1 and hMSH2 genes).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

what criteria is used for HNPCC
-describe this

A

Amsterdam criteria for HNPCC
• At least 3 family members with colon cancer
• The cases span at least two generations
• At least one case diagnosed before the age of 50 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

what is involved in screening for HNPCC in high risk groups?

A

HNPCC screening for ↑ risk group:
• Colonoscopy every 2 years from 20 to 40 years age then annually
• Check mutation in DNA or mismatched repair gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

what is FAP?
-how is this inherited?
-what does this lead to?
-other than colorectal ca what else are these patients higher risk for?

A

Familial Adenomatous Polyposis (FAP) is a rare autosomal dominant condition which leads to the formation of hundreds of polyps by the age of 30-40 years. Patients inevitably develop carcinoma.
Patients with FAP are also at risk from duodenal tumours which is important cause of death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

what is FAP due to?
-how is this tested?

A

It is due to a mutation in a tumour suppressor gene called adenomatous polyposis coli gene (APC), located on chromosome 5. Genetic testing can be done by analysing DNA from a patient’s white blood cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

does FAP affect young or older people

A

Patients generally have a total colectomy with ileo-anal pouch formation in their twenties.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

What is Gardner’s syndrome and what clinical features can this cause?

A

A variant of FAP called Gardner’s syndrome can also feature osteomas of the skull and mandible, can be identified based on oral findings, including multiple impacted and supernumerary teeth, multiple jaw osteomas which give a “cotton-wool” appearance to the jaws, as well as multiple odontomas, Congenital Hypertrophy of the Retinal Pigment Epithelium
(CHRPE), in addition to multiple adenomatous polyps of the colon, thyroid carcinoma and epidermoid cysts on the skin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

What warrants an urgent (within 2 weeks) referral to the colorectal service for investigations ?colon ca?

A

• Patients > 40 years old, reporting rectal bleeding with a change of bowel habit towards looser stools and/or ↑ stool frequency persisting for 6 weeks or more
• Patients > 60 years old, with rectal bleeding persisting for 6 weeks or more without a change in bowel habit and without anal symptoms
• Patients > 60 years old, with a change in bowel habit to looser stools and/or more frequent stools persisting for 6 weeks or more without rectal bleeding
• Any patient presenting with a right lower abdominal mass consistent with involvement of the large bowel
• Any patient with a palpable rectal mass
• Unexplained iron deficiency anemia in men or non-menstruating women (Hb < 11 g/dl in
men, < 10 g/dl in women)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

what is zollinger-ellison syndrome caused by?
-what can this occur as part of?

A

is condition characterized by excessive levels of gastrin, usually from a gastrin secreting tumour usually of the duodenum or pancreas. Around 30% occur as part of MEN type I syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

what are the clinical features of zollinger ellison syndrome?

A

Zollinger-Ellison syndrome typically presents with multiple gastroduodenal ulcers causing abdominal pain, diarrhea and malabsorption. High-dose proton pump inhibitors are needed to control the symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

what is the diagnosis of zollinger ellison syndrome?

A

• Fasting gastrin levels, the single best screen test: done in 3 different days as the gastrin secretion is pulsatile
• Secretin stimulation test: considered +ve if there is ↑ in gastrin >200 pg/mL after secretin injection (Normally Secretin supresses gastrin, but in ZE, it simply shows that the source of gastrin is not the stomach and it is somewhere else like pancresae)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

what is the management of zollinger-ellison syndrome?

A

• If not mets, surgical resection is the cure
• Octreotide can be used to alleviate symptoms with interferon and chemotherapy to attempt cure
non respectable tumor
• PPI is used to control symptoms in acute stages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

Gastric MALT lymphoma:
-what is this assoc with?
-prognosis?
-what does this respond to if low grade?
-what may be found in the blood?

A

• Associated with H. pylori infection in 95% of cases
• Good prognosis
• If low grade then 80% respond to H. pylori eradication
• Paraproteinemia may be present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

What is angiodysplasia?

A

is a vascular deformity of the gastrointestinal tract which predisposes to bleeding and iron deficiency anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

what condition is angiodysplasia associated with?
-what is thought to be caused by?

A

aortic stenosis
The association between angiodysplasia and aortic stenosis is thought to be caused by von Willebrand factor (vWF) being proteolysed in the turbulent blood flow around the aortic valve. vWF is most active in vascular beds with high shear stress, such as angiodysplasia, and deficiency of vWF increases the bleeding risk from such lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

what is used in the diagnosis of angiodysplasia?

A

Diagnosis
• Colonoscopy
• Mesenteric angiography if acutely bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

what is the management for angiodysplasia?

A

Management
• Endoscopic cautery or argon plasma coagulation
• Antifibrinolytics e.g. Tranexamic acid
• Estrogens may also be used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
122
Q

list the causes of acute pancreatitis:

GETSMASHED

A

• Gallstones
• Ethanol
• Trauma
• Steroids
• Mumps (other viruses include Coxsackie B)
• Autoimmune (e.g. Polyarteritis nodosa), Ascaris infection
• Scorpion venom
• Hypertriglyceridemia, Hyperchylomicronemia**, Hypercalcemia, Hypothermia
• ERCP
• Drugs (azathioprine, mesalazine*, didanosine, bendroflumethiazide, furosemide, pentamidine,
steroids, sodium valproate)
• ↑ Degree burn of large skin area with significant inhalation injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
123
Q

describe a rare association with acute pancreatitis seen in the eyes?

A

• Ischemic (Purtscher) retinopathy (cotton wool spots seen on fundoscopy) - may cause temporary or permanent blindness. This condition may be seen following head trauma and in conditions such as acute pancreatitis, fat embolisation, amniotic fluid embolisation, and vasculitic diseases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
124
Q

what is the criteria used in acute pancreatitis for prognosis?

A

• Age > 55
• WBC > 16
• Urea > 16
• Glucose > 11
• Alb < 30
• ALT > 250
• Ca+ < 1
• LDH > 350
• PO2 < 8
• Hematocrit ↓ >10%
• Base deficit > 4
• Fluid loss > 6L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
125
Q

what can be used as a marker of severity in acute pancreatitis on intial assessment?

A

Clinical impression of severity
Body mass index >30
Pleural effusion
APACHE score >8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
126
Q

what can be used as a marker of severity in acute pancreatitis 24 hours after admission

A

Clinical impression of severity
APACHE II >8
Glasgow score of 3 or more
Persisting multiple organ failure
CRP>150

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
127
Q

what can be used as a marker of severity in acute pancreatitis 48hours after admission?

A

Glasgow Score of >3
CRP >150
Persisting or progressive organ failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
128
Q

what is the glasgow panc score?

A

PaO2< 7.9kPa

Age > 55 years

Neutrophils (WBC > 15)

Calcium < 2 mmol/L

Renal function: Urea > 16 mmol/L

Enzymes LDH > 600IU/L

Albumin < 32g/L (serum)

Sugar (blood glucose) > 10 mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
129
Q

what may acute pancreatitis be secondary to in the context of HIV infection?

A

Pancreatitis in the context of HIV infection may be secondary to anti- retroviral treatment (especially didanosine) or by opportunistic infections e.g. CMV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
130
Q

what are 6 causes of high amylase?

A

Acute pancreatitis
Pancreatic pseudocyst
Mesenteric infarct
Perforated viscus
Acute cholecystitis
Diabetic ketoacidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
131
Q

what tests are used in diagnosing acute pancreatitis?

A

Traditionally hyperamylasaemia has been utlilised with amylase being elevated three times the normal range.
However, amylase may give both false positive and negative results.
Serum lipase is both more sensitive and specific than serum amylase. It also has a longer half life.
Serum amylase levels do not correlate with disease severity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
132
Q

describe the management of acute pancreatitis:
-three main areas of management

A

Nutrition
-There is reasonable evidence to suggest that the use of enteral nutrition does not worsen the outcome in pancreatitis
-Most trials to date were underpowered to demonstrate a conclusive benefit.
-The rationale behind feeding is that it helps to prevent bacterial translocation from the gut, thereby contributing to the development of infected pancreatic necrosis.

Use of antibiotic therapy
-Many UK surgeons administer antibiotics to patients with acute pancreatitis.
-A recent Cochrane review highlights the potential benefits of administering Imipenem to patients with established pancreatic necrosis in the hope of averting the progression to infection.
-There are concerns that the administration of antibiotics in mild attacks of pancreatitis will not affect outcome and may contribute to antibiotic resistance and increase the risks of antibiotic associated diarrhoea.

Surgery
-Patients with acute pancreatitis due to gallstones should undergo early cholecystectomy.
-Patients with obstructed biliary system due to stones should undergo early ERCP.
-Patients who fail to settle with necrosis and have worsening organ dysfunction may require debridement, fine needle aspiration is still used by some.
-Patients with infected necrosis should undergo either radiological drainage or surgical necrosectomy. The choice of procedure depends upon local expertise.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
133
Q

what is chronic pancreatitis?
-what does this affect?
-what is this due to?

A

Chronic Pancreatitis is an inflammatory condition which can ultimately affect both the exocrine and endocrine functions of the pancreas. Around 80% of cases are due to alcohol excess with up to 20% of cases being unexplained.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
134
Q

describe 3 features of chronic pancreatitis?

A

• Pain is typically worse 15 to 30 minutes following a meal
• Steatorrhoea: symptoms of pancreatic insufficiency usually develop between 5 and 25 years
after the onset of pain
• Diabetes mellitus develops in the majority of patients. It typically occurs more than 20 years
after symptom begin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
135
Q

what are the 3 investigations used for chronic pancreatitis?

A

• Abdominal x-ray shows pancreatic calcification in 30% of cases
• CT is more sensitive at detecting pancreatic calcification
• Functional tests: pancreolauryl and Lundh tests may be used to assess exocrine function if
imaging inconclusive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
136
Q

what is the management of chronic pancreatitis?

A

Management
• Pancreatic enzyme supplements
• Analgesia
• Antioxidants: limited evidence base - one study suggests benefit in early disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
137
Q

what are 5 local complications in acute pancreatitis?

A

Peripancreatic fluid collections

Pseudocysts

Pancreatic necrosis

Pancreatic abscess

Haemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
138
Q

Peripancreatic fluid collections:
-how often do these occur?
-where are these usually located?
-what can these develop into?
-what is the treatment?

A

Occur in 25% cases
Located in or near the pancreas and lack a wall of granulation or fibrous tissue
May resolve or develop into pseudocysts or abscesses
Since most resolve aspiration and drainage is best avoided as it may precipitate infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
139
Q

Pseudocysts in acute pancreatitis:
-how do these form? what is the nature of them?
-when do these usually occur?
-what are the investigations for these?
-when can these be diagnosed?
-what is the treatment?

A

-In acute pancreatitis result from organisation of peripancreatic fluid collection. They may or may not communicate with the ductal system.
-The collection is walled by fibrous or granulation tissue and typically occurs 4 weeks or more after an attack of acute pancreatitis
-Most are retrogastric
-75% are associated with persistent mild elevation of amylase
-Investigation is with CT, ERCP and MRI or endoscopic USS
-They cannot be diagnosed until more than 6 weeks after the acute attack
-Symptomatic cases may be observed for 12 weeks as up to 50% resolve
-Treatment is either with endoscopic or surgical cystogastrostomy or aspiration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
140
Q

Pancreatic necrosis in acute pancreatitis:
-what can this involve?
-what do complications from this link to?
-how are these managed?

A

Pancreatic necrosis may involve both the pancreatic parenchyma and surrounding fat
Complications are directly linked to extent of parenchymal necrosis and extent of necrosis overall
Early necrosectomy is associated with a high mortality rate (and should be avoided unless compelling indications for surgery exist)
Sterile necrosis should be managed conservatively (at least initially)
Some centres will perform fine-needle aspiration sampling of necrotic tissue if infection is suspected. False negatives may occur and the extent of sepsis and organ dysfunction may be a better guide to surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
141
Q

Pancreatic abscess in acute pancreatitis:
-what is this?
-what do these occur as a result of?
-what is the treatment?

A

Intraabdominal collection of pus associated with pancreas but in the absence of necrosis
Typically occur as a result of infected pseudocyst
Transgastric drainage is one method of treatment, endoscopic drainage is an alternative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
142
Q

Haemorrhage as a local complication of acute pancreatitis:
-how can this develop?
-what sign can develop?

A

Infected necrosis may involve vascular structures with resultant haemorrhage that may occur de novo or as a result of surgical necrosectomy.
When retroperitoneal haemorrhage occurs Grey Turner’s sign may be identified

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
143
Q

What is the systemic complication of pancreatitis?

A

Acute respiratory distress syndrome
associated with a high-mortality rate of around 20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
144
Q

what are the symptoms of pancreatic pseudocyst?

A

• Abdominal pain or a mass.
• Fever
• Persistently raised amylase and liver function tests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
145
Q

what are the two cystic tumours that can occur in the pancreas?
-are these benign/malignant

A

• Serous cystadenoma: benign and remain benign.
• Mucinous cystadenoma: this may be benign but has the potential to become malignant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
146
Q

what are the investigations for cystic tumours in the pancreas?
-how to distinguish between serous cystadenoma and mucinoous cystadenoma?

A

• CT or MRI can distinguish between the two.
• Aspiration of the cyst for cytology and carcinogenic embryonic antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
147
Q

what is the management of:
-mucinous neoplasm
-serous cystadenoma or asymptomatic pseudocyst

A

• Mucinous neoplasm: most patients undergo limited surgery of the pancreatic cyst.
• Serous cystadenoma or aymptomatic pseudocyst: can also be associated with polycystic kidney disease and von Hippel–Lindau disease. Considerable debate exists as to whether follow up is necessary; in younger patients it may not be. Anyhow, guidelines generally recommend annual
review for a period of around 4 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
148
Q

pancreatic cancer:
-incidence
-more males or females?
-what is the 5 year survival rate
-what is the most common oncogene
-what is the commonest form of endocrine tumour
-which age is affected?

A

• Incidence in the West: 9 cases per 100 000 and it’s increasing over the last 20 years.
• 60% are ♂
• 5-year survival rate: 2%
• K-ras is the most common oncogene in this condition
• Insulinomas are the commonest form of endocrine tumours of the pancreas
• Majority of cases occur in patients over the age of 60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
149
Q

what are 9 assoc. with pancreatic ca?

A

• Smoking (with a twofold increase in incidence)
• Diabetes
• Chronic pancreatitis
• Hereditary pancreatitis
• Hereditary non-polyposis colorectal carcinoma
• Multiple endocrine neoplasia
• Peutz-jeghers syndrome
• BRCA2
• Dysplastic naevus syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
150
Q

what is included in the investigation of pancreatic ca?

A

• Contrast CT is used for diagnosis and assessment of invasion
• ERCP restricted to palliative care
• CA 19-9
• U/S abdomen is less reliable when the tumor is in the body or tail

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
151
Q

describe the management of pancreatic cancer?

A

• Surgical intervention represents the only chance of long-term survival with < 20% suitable for surgery at diagnosis. Eligibility for resection depend on:
“ Tumor size < 4cm
“ Invasion of superior mesenteric artery or portal vein
“ Presence of mets
• Radio and chemotherapy are ineffective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
152
Q

what is Cowden’s syndrome?
-what tumour suppressor gene is involved?

A

Cowden’s syndrome is an inherited condition resulting from a defect in the PTEN tumour suppressor gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
153
Q

what are the manifestations of cowden’s syndrome?
-why is it important to diagnose this early?
-what kind of dysfunction is seen even in the abscence of cancer?

A

Hamartomatous polyps of the GI tract are often the first manifestation along with characteristic muco-cuteneous lesions such as oral mucosal papillomas, palmoplantar keratoses and trichilemmomas (benign tumours of hair follicles).
The syndrome is important to diagnose early because of the high risk of malignancy, particularly of the breast and thyroid. Thyroid dysfunction is common even in the absence of cancer.

154
Q

what is familial juvenile polyposis?

A

Familial juvenile polyposis also results in multiple polyps in the colon identical to those found in Cowden’s syndrome but the associated oral lesions are absent.

155
Q

what are the intestinal causes of malabsorption?

A

• Coeliac disease
• Crohn’s disease
• Tropical sprue
• Whipple’s
• Giardiasis
• Brush border
enzyme deficiencies (e.g. ↓ Lactase)

156
Q

what are the pancreatic causes of malabsorption?

A

• Chronic pancreatitis
• Cystic fibrosis
• Pancreatic cancer

157
Q

what are the biliary causes of malabsorption?

A

• Biliary obstruction
• Primary biliary cirrhosis

158
Q

what can:
• Bacterial overgrowth (e.g. Systemic sclerosis, diverticulae, blind loop)
• Short bowel syndrome
• Lymphoma
cause

A

malabsorption

159
Q

Crohns or UC:
• Bloody diarrhoea more common
• Abdominal pain in the left lower
quadrant
• Tenesmus

A

UC

160
Q

Crohns or UC:
• Diarrhoea usually non-bloody
• Weight loss more prominent
• Upper GI symptoms, mouth ulcers,
perianal disease
• Abdominal mass palpable in the right
iliac fossa

A

Crohns

161
Q

Crohn’s or UC:
assoc with Primary sclerosing cholangitis

A

UC

162
Q

Does Crohns or UC increase the risk of colorectal cancer?

A

• Risk of colorectal cancer high in UC than CD

163
Q

Crohns or UC:
• Obstruction, fistula as complications

A

Crohns

164
Q

Describe the pathology found in UC?
what antigen is this assoc with?

A

• Inflammation always starts at rectum and never spreads beyond ileocaecal valve
• Continuous disease
• Associated with pANCA antigen

165
Q

Describe the pathology found in Crohn’s
what antibodies is this assoc. with?

A

• Lesions may be seen anywhere from the mouth to anus
• Skip lesions may be present
• Associated with ASCA (Anti-
Saccharomyces Cerevisiae Antibodies

166
Q

Describe the histology found in UC:
-where is inflammation found?
-what happens on a cellular level

A

• No inflammation beyond submucosa (unless fulminant disease) - inflammatory cell infiltrate in lamina propria
• neutrophils migrate through the walls of glands to form crypt abscesses
• depletion of goblet cells and mucin from gland epithelium

167
Q

Describe the histology found in Crohns?
-where is the inflammation found?

A

• Inflammation in all layers from mucosa to serosa
• goblet cells
• granulomas

168
Q

what is seen on endoscopy in UC?

A

• Widespread ulceration with preservation of adjacent mucosa which has the appearance of polyps (‘pseudopolyps’)

169
Q

what is seen on endoscopy in Crohns?

A

Deep ulcers, skip lesions

170
Q

what is the radiological investigation for UC
-what is seen?

A

Barium enema
• loss of haustrations
• superficial ulceration, ‘pseudopolyps’ • long standing disease: colon is narrow and short -‘drainpipe colon’

171
Q

what is the radiological investigation for crohns
-what is seen?

A

Small bowel enema
• high sensitivity and specificity for examination of the terminal ileum
• strictures: ‘Kantor’s string sign’
• proximal bowel dilation
• ‘rose thorn’ ulcers
• fistulae

172
Q

what is the treatment divided into for UC?

A

Inducing remission
Maintaining remission

173
Q

what is used to induce remission in UC?

A

• Treatment depends on the extent and severity of disease
• Rectal aminosalicylates or steroids: for distal colitis rectal mesalazine has been shown to be superior to rectal steroids
• Oral aminosalicylates or steroids
• Severe colitis should be referred to hospital

In severe ulcerative colitis, patients should be treated with intravenous treatments including steroids, fluids, subcutaneous heparin and elemental diet. The patient should also have daily examination and monitoring including review by surgeons, blood tests, stool chart, heart rate, temperature and abdominal X-rays. intravenous steroids are usually given first-line

(intravenous ciclosporin may be used if steroid are contraindicated if after 72 hours there has been no improvement, consider adding intravenous ciclosporin to intravenous corticosteroids or consider surgery)

DON’T GIVE ANTI-DIARRHEAL Rx FOR ACUTE COLLITIS → TOXIC MEGACOLON

174
Q

what criteria is used to determine severity in UC?

A

(Truelove and Witt criteria)
Severe ulcerative colitis = 30% risk of colectomy

> 6 bloody stools/24 hour
+
1 or more of
-Fever (>37.8°C)
-Tachycardia (>90/min)
-Anaemia (Haemoglobin <10.5g/dl)
-Elevated ESR (>30mm/hr)

The severity of UC is usually classified as being mild, moderate or severe:

mild: < 4 stools/day, only a small amount of blood
moderate: 4-6 stools/day, varying amounts of blood, no systemic upset
severe: >6 bloody stools per day + features of systemic upset (pyrexia, tachycardia, anaemia, raised inflammatory markers)
175
Q

what is used to maintain remission in UC?

A

Following a mild-to-moderate ulcerative colitis flare

proctitis and proctosigmoiditis
    topical (rectal) aminosalicylate alone (daily or intermittent) or
    an oral aminosalicylate plus a topical (rectal) aminosalicylate (daily or intermittent) or
    an oral aminosalicylate by itself: this may not be effective as the other two options
left-sided and extensive ulcerative colitis
    low maintenance dose of an oral aminosalicylate

Following a severe relapse or >=2 exacerbations in the past year

oral azathioprine or oral mercaptopurine
176
Q

describe the screening programme for concomitant UC and PSC

A

Patients with concomitant UC and PSC are at ↑ risk of developing colonic cancer, and it is recommended that they be screened annually with colonoscopy.
Patients with extensive UC should be screened 8 to10 years from the onset of symptoms. Colonoscopy should be performed:
• 3-yearly in the second decade
• 2-yearly in the third decade
• Yearly by the fourth decade.

Patients post-liver transplant for PSC still should have yearly screening. Each case should be considered for the benefits and risks of the colonoscopy.

177
Q

what are the extra-intestinal features common to both crohns and UC and are related to disease activity?

A

Arthritis: pauciarticular, asymmetric
Erythema nodosum
Episcleritis
Osteoporosis

Arthritis is the most common extra-intestinal feature in both CD and UC
Episcleritis is more common in CD

178
Q

what are the extra-intestinal features common to both crohns and UC and are not related to disease activity?

A

Arthritis: polyarticular, symmetric
Uveitis
Pyoderma gangrenosum
Clubbing
Primary sclerosing cholangitis

Primary sclerosing cholangitis is much more common in UC
Uveitis is more common in UC

179
Q

what factors in UC increase the risk of Ca?

A

• Disease duration > 10 years
• Patients with pancolitis
• Onset before 15 years old
• Unremitting disease
• Poor compliance to treatment

180
Q

which blood test correlates well with disease activity in crohn’s disease?

A

C-reactive protein correlates well with disease activity

181
Q

what is the investigation of choice in crohns and what is seen?

A

o Colonoscopy is the investigation of choice
o Features suggest of crohn’s include deep ulcers, skip lesions

182
Q

what lifestyle factor is implicated in Crohn’s disease?

A

• Patients should be strongly advised to stop smoking
• Some studies suggest an ↑ risk of relapse secondary to NSAIDs and the combined oral
contraceptive pill but the evidence is patchy

183
Q

what 5 agents can be used in active crohns?

A

• Mesalazine: whilst evidence base is limited widely used in active disease
• Steroids (oral, topical or intravenous)
• Azathioprine is used as a second-line treatment in active disease
• Mercaptopurine (also called 6-mercaptopurine, 6-MP)
• Methotrexate is used in patients intolerant of azathioprine or refractory disease. Usually given intramuscularly, but not effective in maintaining remission. Significant anemia is a contra- indication for methotrexate.
• Infliximab is useful in refractory disease and fistulating crohn’s. Patients typically continue on azathioprine or methotrexate

184
Q

Activity of what enzyme needs to be assessed prior to azathioprine or meraptopurine administration?

A

*assess thiopurine methyltransferase (TPMT) activity before offering azathioprine or mercaptopurine

185
Q

what is first line treatment for peri-anal disease in crohns?

A

Perianal disease: Metronidazole is first-line

186
Q

what is whipples disease caused by?
-which HLA is this assoc with?
-which demographic is usually affected?

A

Whipple’s disease is a rare multi-system disorder caused by Tropheryma whippelii infection. It is more common in those who are HLA-B27 positive and in middle-aged men

187
Q

what are the 6 causes of whipples disease?

A

• Malabsorption: diarrhea, weight loss
• Large-joint arthralgia (seronegative arthropathy)
• Lymphadenopathy
• Skin: hyperpigmentation and photosensitivity
• Pleurisy, pericarditis
• Neurological symptoms (rare): ophthalmoplegia, dementia, seizures, ataxia, myoclonus

188
Q

what is seen on jejunal biopsy and blood test in whipples disease?

A

• Jejunal biopsy shows deposition of macrophages containing Periodic acid-Schiff (PAS) granules
• ↑ CRP and ESR
• Hypoalbuminemia

189
Q

what is the management of whipples disease?

A

Management
• Varies e.g. IV penicillin then oral co-trimoxazole for a year

190
Q

what is the triad of microscopic colitis?
- what does it include?
-is this common and who does this affect?

A

Microscopic colitis: is defined by the triad of:
1. Watery diarrhea
2. Normal colonoscopy
3. ↑ Inflamation of the lamina propria of the colon.

This disease includes collagenous and lymphocytic colitis. It is an uncommon disease with an incidence of 5/100,000 per year and frequents the elderly (mean age 55-68) and women.

191
Q

what are 4 assoc with microscopic colitis?

A

• NSAIDs
• Omeprazole, Lansoprazole
• Ticlopidine
• Cimetidine

192
Q

what is the treatment of microscopic colitis?

A

Treatment: includes just stopping the offending medication. Corticosteroids, cholestyramine and now bismuth have been used as treatment with some effect. Recurrence however, does occur.

193
Q

when should the diagnosis of IBS be considered?

A

The diagnosis of IBS should be considered if the patient has had the following for at least 6 months:
• Abdominal pain, and/or
• Bloating, and/or
• Change in bowel habit

194
Q

When should a positive diagnosis of IBS be made?

A

A positive diagnosis of IBS should be made is the patient has abdominal pain relieved by defecation or associated with altered bowel frequency stool form, in addition to 2 of the following 4 symptoms:
• Altered stool passage (straining, urgency, incomplete evacuation)
• Abdominal bloating (more common in women than men), distension, tension or hardness
• Symptoms made worse by eating
• Passage of mucus

Features such as lethargy, nausea, backache and bladder symptoms may also support the diagnosis

195
Q

what are the ‘red flag features’ to enquire about when considering IBS?

A

Red flag features should be enquired about:
• Rectal bleeding
• Unexplained/unintentional weight loss
• Family history of bowel or ovarian cancer
• Onset after 60 years of age

196
Q

what are the suggested primary care investigations in IBS?

A

Suggested primary care investigations are:
• Full blood count
• ESR
• CRP
• Coeliac disease screen (antiendomysial antibodies or tissue transglutaminase)

197
Q

what is the first line pharmacological management in IBS?

A

First-line pharmacological treatment - according to predominant symptom
• Pain: antispasmodic agents
• Constipation: laxatives but avoid lactulose
• Diarrhea: loperamide is first-line

198
Q

what are the second line pharmacological management in IBS?

A

Second-line pharmacological treatment
• low-dose tricyclic antidepressants (e.g. amitriptyline 5-10 mg) are used in preference to selective serotonin reuptake inhibitors

199
Q

what psychological therapies can be used for IBS and when should these be implemented?
-what about acupuncture/reflexology

A

Other management options
• Psychological interventions - if symptoms do not respond to pharmacological treatments after 12 months and who develop a continuing symptom profile (refractory IBS), consider referring for cognitive behavioural therapy, hypnotherapy or psychological therapy
• Complementary and alternative medicines: ‘do not encourage use of acupuncture or reflexology for the treatment of IBS’

200
Q

describe what dietary advice can be given for patients with IBS?

A

• Have regular meals and take time to eat
• Avoid missing meals or leaving long gaps between eating
• Drink at least 8 cups of fluid per day, especially water or other non-caffeinated drinks such as
herbal teas
• Restrict tea and coffee to 3 cups per day
• ↓ intake of alcohol and fizzy drinks
• Consider limiting intake of high-fibre food (for example, wholemeal or high-fibre flour and
breads, cereals high in bran, and whole grains such as brown rice)
• ↓ intake of ‘resistant starch’ often found in processed foods
• Limit fresh fruit to 3 portions per day
• For diarrhea, avoid sorbitol
• For wind and bloating consider increasing intake of oats (for example, oat-based breakfast
cereal or porridge) and linseeds (up to one tablespoon per day).

201
Q

what is coeliac disease?

A

Coeliac Disease: is caused by sensitivity to the protein gluten. Repeated exposure leads to villous atrophy which in turn causes malabsorption.

202
Q

what conditions are associated with coeliac disease?
-what HLA are involved?

A

Conditions associated with coeliac disease include dermatitis herpetiformis (a vesicular, pruritic skin eruption) and autoimmune disorders (type 1 diabetes mellitus and autoimmune hepatitis).

It is strongly associated with HLA-DQ2 (95% of patients) and HLA-B8 (80%) as well as HLA-DR3 and HLA-DR7

203
Q

what is the management of coeliac disease:
-what are gluten containing foods?
-what are some gluten -free foods?

A

The management of coeliac disease involves a gluten-free diet. Gluten containing cereals include:
• Wheat: bread, pasta, pastry
• Barley*: beer
• Rye
• Oats**
Some notable foods which are gluten-free include:
• Rice
• Potatoes
• Corn (maize)

204
Q

what are 8 features that should prompt screening for coeliac disease

A

? Chronic or intermittent diarrhea
? Failure to thrive or faltering growth (in children)
? Persistent or unexplained gastrointestinal symptoms including nausea and vomiting
? Prolonged fatigue (‘tired all the time’)
? Recurrent abdominal pain, cramping or distension
? Sudden or unexpected weight loss
? Unexplained iron-deficiency anemia, or other unspecified anemia
? Recurrent mouth ulcers

205
Q

what 5 conditions should prompt screening of coeliac disease?

A

? Autoimmune thyroid disease
? Dermatitis herpetiformis
? Irritable bowel syndrome
? Type 1 diabetes
? First-degree relatives (parents, siblings or children) with coeliac disea

206
Q

what 7 complications can arise from coeliac disease?

A

• Anemia: iron, folate and vitamin B12 deficiency (folate deficiency is more common than vitamin B12 deficiency in coeliac disease)
• Hyposplenism
• Osteoporosis
• Lactose intolerance
• Enteropathy-associated T-cell lymphoma of small intestine
• Subfertility, unfavourable pregnancy outcomes
• Rare: esophageal cancer, other malignancies

207
Q

what 2 investigations are used to diagnose coeliac disease?
-what needs to be done prior to this?

A

Immunological testing and jejunal biopsy

NICE issued guidelines on the investigation of coeliac disease in 2009. If patients are already taking a gluten-free diet they should be asked, if possible, to reintroduce gluten for at least 6 weeks prior to testing

208
Q

what 4 immunological studies are used for coeliac disease?

A

• Tissue transglutaminase (TTG) antibodies (IgA) are first-choice according to NICE
• Endomyseal antibody (IgA)
• Anti-gliadin antibody (IgA or IgG) tests are NOT recommended by NICE
• Anti-casein antibodies are also found in some patients

209
Q

what is seen on jejunal biopsy in coeliac disease?

A

• Villous atrophy
• Crypt hyperplasia
• ↑ in intraepithelial lymphocytes
• Lamina propria infiltration with lymphocytes

210
Q

what is tropical sprue?

A

Tropical Sprue: this disease is most common in the Carribbean and the Far-East. It is characterized by a picture of small intestinal malabsorption and the cause is thought to be infectious in origin

211
Q

what is used for the diagnosis of tropical sprue?
-what is seen on this investigation?

A

Diagnosis:
• Jejunal biopsy reveals:
o Mild villous atrophy
o ↑ villous crypts
o Mononuclear cellular infiltrates
o Enlarged epithelial cells
o Large nuclei caused by folate and/or vitamin B12 deficiency.

212
Q

what is the treatment for tropical sprue?

A

Treatment:
• Tetracyclines 250mg qds up to 6 months
• Ampicillin may be used as an alternative in patients who are intolerant of tetracyclines.
• Folate and B12 deficiencies should also be corrected
• Complete recovery is possible with appropriate therapy.

213
Q

what are 6 causes of jejunal villous atrophy?
-which is most common?

A

• Coeliac disease - most common
• Tropical sprue
• Hypogammaglobulinemia
• Gastrointestinal lymphoma
• Whipple’s disease
• Cow’s milk intolerance

214
Q

what constitutes toxic megacolon

A

Toxic Megacolon: usually ssociated with severe colitis (criteria mentioned above). The colon is dilated when it is measured > 5.5cm

215
Q

what is the main treatment for toxic megacolon?
-what is diameters are used to assess for improvement?
-if there is no improvement what should be done?

A

• Toxic dilatation can be treated medically for 12-24 hours with IV and rectal hydrocortisone but if there is then no improvement in the triad of
o Pulse
o Stool frequency
o Colon dilatation
• Patient should undergo an urgent colectomy.

Otherwise, there is an increased risk of perforation, which has a mortality of 30%.

• In addition to steroids, the acutely unwell patient should receive: o K+ supplementation
o Thromboembolism prophylaxis.
• Antibiotics have not been demonstrated to help

216
Q

what is short bowel syndrome?

A

Short Bowel Syndrome: in patients who have removal of more than one-half of the small intestine, malabsorption syndrome may result. It may occur in patients with Crohn’s disease or those with ischemic bowel who have undergone significant bowel resection.

217
Q

what is the presentation of short bowel syndrome?

A

Presentation:
• Diarrhoea
• Steatorrhoea
• Malabsorption manifestation: Weight loss, anemia, osteoporosis/osteomalacia, electrolyte
disturbances and hypovolemia.

218
Q

what is the management of short bowel syndrome?

A

Management:
• In patients with > 100cm of jejunum, oral intake is still possible. Diarrhoea may reduce with lactose exclusion or with a course of metronidazole to eradicate bacterial overgrowth.
• In patients with < 100cm of jejunum, total parenteral nutrition is recommended.

219
Q

what is melanosis coli?
-what does histology show?
-what is this assoc. with?

A

Melanosis coli is a disorder of pigmentation of the bowel wall. Histology demonstrates pigment- laden macrophages. It is associated with laxative abuse, especially anthraquinone compounds such as senna

220
Q

what is the diagnosis of SBP?

A

Diagnosis
• Paracentesis: neutrophil count > 250 cells/ul

221
Q

what is the management of SBP?

A

Management
• Intravenous cefotaxime is usually given
• Patients who have had an episode of SBP should be on prophylactic antibiotics

222
Q

what is a marker of poor prognosis in SBP?

A

Alcoholic liver disease is a marker of poor prognosis in SBP.

223
Q

what is the old classification of ascites?

A

Transudate (protein < 30g/l)
Exudate (protein > 30g/l)

224
Q

what are the causes for a transudate ascitic tap?

A

• Cirrhosis and portal hypertension
• Nephrotic syndrome
• Cardiac failure
• Budd–Chiari syndrome
• Myxodema

225
Q

what are the causes for an exudative ascitic tap?

A

• Intra-abdominal tuberculosis
• Pancreatitis.
• Hepatic or peritoneal malignancy

226
Q

what is the new classification for ascites?
- what terms should replace transudative and exudative

A

However the serum-ascites albumin gradient (SAAG) has now largely replaced this concept and is the best single test for classifying ascites into portal hypertensive (SAAG >1.1 g/dL) and non–portal hypertensive (SAAG <1.1 g/dL) causes. The terms high-albumin gradient and low-albumin gradient should replace the terms transudative and exudative in the description of ascites

227
Q

what are the causes for a high albumin gradient ascites?

A

• Cirrhosis
• Alcoholic hepatitis
• Schistosomiasis
• Fulminant hepatic failure
• Budd–Chiari syndrome
• Acute or chronic portal vein obstruction
• Cardiac diseases
• Spontaneous bacterial peritonitis
secondary to cirrhosis.

228
Q

what are the causes for a low albumin gradient ascites?

A

• • • • • •
Nephrotic syndrome
Protein losing enteropathy
Peritoneal carcinomatosis
Tuberculous peritonitis
Pancreatic duct leak
Biliary ascites.

229
Q

bilirubin:
-what is this a product of?
-how is this excreted?

A

Bilirubin:
o Bilirubin is derived from the breakdown of heme in the red blood cells within the
reticuloendothelial system.
o The unconjugated bilirubin then binds albumin and is taken up by the liver.
o In the liver it is conjugated which then makes it water-soluble and thus allows it to be
excreted into the urine.
o Normally total serum bilirubin is measured; however, the unconjugated (indirect bilirubin)
and conjugated (direct bilirubin) portions can be.

230
Q

is albumin useful in the acute stages of liver disease?

A

Albumin - sensitive marker of hepatic function, but not useful in the acute stages as it has a long half life (20 days).

231
Q

What are the transferases?
-where do they usually reside and why is that important?
-which is more specific to the liver?
-what do very high levels suggest?
-what can ratios of these indicate?

A

Transferases - usually either alanine aminotransferase (ALT) or aspartate aminotransferase (AST); rarely does a laboratory routinely provide both:
o These enzymes normally reside inside cells (in cytoplasm) so raised levels usually represent hepatocellular damage. ALT is more specific to the Liver, as AST is also found in cardiac and skeletal muscle and red blood cells.
o Very high levels (>1000 IU/L) suggest drug-induced hepatitis (e.g. paracetamol), acute viral hepatitis (A or B), ischemic, or rarely, autoimmune hepatitis.
o The ratio of AST to ALT can give some extra clues as to the cause:
$ In chronic Liver disease ALT >AST, once cirrhosis established AST >ALT
$ The extremes of the ratio of AST:ALT can also be helpful:
! >2 suggests alcoholic liver disease.
! <1.0 suggests nonalcoholic liver disease.

232
Q

what does GGT relate to?
-when is this typically elevated?
-if ALP is normal what can this indicate?

A

• Gamma-glutamyltransferase (GGT) - also related to the bile ducts. Typically elevated in cholestasis (with elevated ALP) but, if ALP normal, suggests induction of hepatic metabolic enzymes (e.g alcohol or enzyme-inducing drugs).

233
Q

Where does ALP come from:
when is this raised?
when is the physiologically increased?

A

• Alkaline phosphatase (ALP) - comes mainly from the cells lining bile ducts but also in bone. Marked elevation is typical of cholestasis (often with elevated GGT) or bone disorders (usually normal GGT). Isoenzyme analysis may help identify source. It is physiologically increased when there is increased bone turnover (e.g. adolescence) and is elevated in the third trimester of pregnancy (produced by the placenta).

234
Q

If there’s a high serum bilirubin but a low urine bilirubin what does this indicate?

A

When Bilirubin is elevated and it’s mentioned that no bilirubin in uring dipstick

Unconjugated Bilirubin

235
Q

Describe the hepatomegaly felt in cirrhosis?

A

• Cirrhosis: if early disease, but later liver ↓ in size. Associated with a non-tender, firm liver

236
Q

Describe the hepatomegaly felt in malignancy?

A

• Malignancy: metastatic spread or primary hepatoma. Associated with a hard, irregular. Liver
edge

237
Q

Describe the hepatomegaly felt in right heart failure?

A

Right heart failure: firm, smooth, tender liver edge. May be pulsatile

238
Q

Hepatomegaly + dupuytren’s contracture + parotitis
-what is this assoc with?

A

alcoholic liver disease

239
Q

what are 6 causes of hepatosplenomegaly

A

• Chronic liver disease* with portal hypertension
• Infections: glandular fever, malaria, hepatitis
• Lymphoproliferative disorders
• Myeloproliferative disorders e.g. CML
• Amyloidosis
*the latter stages of cirrhosis are associated with a small liver

240
Q

what is primary biliary cirrhosis?
-what is this typically seen in?
-what causes this and what HLA is assoc?
-what is the pathophysiology?
-what is the classic presentation?

A

is chronic liver disorder typically seen in middle-aged ♀s (♀:♂ ratio of 9:1).
The aetiology is not fully understood although it is thought to be an autoimmune condition, with HLA DR3 association.
Interlobular bile ducts become damaged by a chronic inflammatory process causing progressive cholestasis, which may eventually progress to cirrhosis.
The classic presentation is itching in a middle-aged woman

241
Q

What are:
• Sjogren’s syndrome (seen in up to 80% of patients)
• Rheumatoid arthritis
• Systemic sclerosis
• Thyroid disease
• Membranous GN
• Renal Tubular Acidosis

all assoc of?

A

primary biliary cirrhosis

242
Q

Describe the clinical features of primary biliary cirrhosis
-early features
-late features

A

• Early: may be asymptomatic (e.g. Raised ALP on routine LFTs) or fatigue, pruritus
• Cholestatic jaundice
• Hyperpigmentation, especially over pressure points
• Xanthelasmas, xanthomata
• Also: clubbing, hepatosplenomegaly
• Late: may progress to liver failure

243
Q

what is the diagnosis of primary biliary cirrhosis?

A

Diagnosis
• Anti-mitochondrial antibodies (AMA) M2 subtype in 98% of patients and are highly specific.
• Smooth muscle antibodies in 30% of patients
• Raised serum IgM

244
Q

what is the management in primary biliary cirrhosis?

A

Management
• Median survival is 7-10 yrs, but ↓ to 2 yrs if jaundice is present
• Pruritus: cholestyramine
• Fat-soluble vitamin supplementation
• Ursodeoxycholic acid
• Liver transplantation e.g. If bilirubin > 100 (PBC is a major indication) - recurrence in graft can occur but is not usually a problem. 5 yr survival post transplant 80%

245
Q

what is the ‘M’ rule in primary biliary cirrhosis?

A

Primary biliary cirrhosis - the M rule
• IgM
• Anti-Mitochondrial antibodies, M2 subtype
• Middle aged ♀s

246
Q

what are 4 complications of primary biliary cirrhosis?

A

Complications
• Malabsorption: osteomalacia, coagulopathy
• Sicca syndrome (Sjögren’s syndrome) occurs in 70% of cases
• Portal hypertension: ascites, variceal hemorrhage
• Hepatocellular cancer (20-fold ↑ risk)

247
Q

what is primary sclerosis cholangitis?

A

Primary sclerosing cholangitis is a biliary disease of unknown aetiology characterized by inflammation and fibrosis of intra and extra-hepatic bile ducts

248
Q

what are the 3 assoc conditions with primary sclerosing cholangitis?

A

Associations
• Ulcerative colitis: 4% of patients with UC have PSC, 80% of patients with PSC have UC
• Crohn’s (much less common association than UC)
• HIV

249
Q

what are the features of primary sclerosing cholangitis?

A

Features
• Cholestasis
• Hepatomegaly
• Intermittent jaundice

250
Q

what investigations are used for primary sclerosing cholangitis?

A

Investigation
• ERCP is the standard diagnostic tool, showing multiple biliary strictures giving a ‘beaded’ appearance
• MRCP is superior to ERCP
• ANCA may be positive
• There is a limited role for liver
biopsy, which may show fibrous, obliterative cholangitis often described as ‘onion skin’

251
Q

what are the complicaions of primary sclerosing cholangitis?

A

Complications
• Cholangiocarcinoma (in 10%)
• ↑ risk of colorectal cancer

252
Q

what is the management of primary sclerosing cholangitis?

A

Management:
• Liver transplantation, survival post transplant is 90% although rejection is high.

Indication for transplantation:
o Bilirubin > 100 μmol/l
o Recurrent bacterial cholangitis
o Ascitis
o Refractoryitching
o Cholangiocarcinoma is a contraindication for transplantation

253
Q

why is the most common cause of biliary disease in patients with HIV PSC?

A

The most common cause of biliary disease in patients with HIV is sclerosing cholangitis due to infections such as CMV, Cryptosporidium and Microsporidia

254
Q

what is wilson’s disease?
-how is this inherited
-what gene defect is implicated for wilsons disease?

A

Wilson’s Disease is an autosomal recessive disorder characterized by excessive copper deposition in the tissues. Metabolic abnormalities include ↑ copper absorption from the small intestine and ↓ hepatic copper excretion. Wilson’s disease is caused by a defect in the ATP7B gene located on chromosome 13.

255
Q

what is the onset of symptoms in Wilson’s disease?
-what do children present with vs young adults?

A

The onset of symptoms is usually between 10 - 25 years. Children usually present with liver disease whereas the first sign of disease in young adults is often neurological disease

256
Q

what are the features of wilson’s disease?

A

Features result from excessive copper deposition in the tissues, especially the brain, liver and cornea:
• Liver: hepatitis, cirrhosis
• Neurological: speech and behavioral problems are often the first manifestations.
Also: tremor, chorea
• Kayser-fleischer rings
• Renal tubular acidosis (esp. Fanconi syndrome)
• Hemolysis
• Blue nails

257
Q

what should Combination of parkinsonism + chronic liver disease in a young person make you think of?

A

Wilson’s disease

258
Q

what is the diagnosis of wilson’s disease?

A

Diagnosis
• ↓ serum ceruloplasmin
• ↑ 24hr urinary copper excretion
• Slit lamp: Kayser-Fleischer ring

259
Q

what is the management of wilson’s disease?

A

Management
• D-penicillamine: chelates copper 1.5-2g/day in divided dose then 0.75-1.5g/day maintenance
• Trientine
• Zinc

260
Q

what is gilberts syndrome?
-what is this caused by?
-what are common triggers?

A

Gilbert’s syndrome is an autosomal recessive condition of defective bilirubin conjugation due to a deficiency of UDP glucuronyl transferase.
The prevalence is approximately 1-2% in the general population.
Viral infections are common triggers for a rise in the bilirubin in patients with Gilbert’s

261
Q

what are the features of gilberts syndrome?

A

Features
• Isolated hyperbilirubinemia
• Unconjugated hyperbilirubinemia (i.e. Not in urine)
• Jaundice may only be seen during an intercurrent illness

262
Q

what are the investigations for gilberts syndrome? what is the management?

A

Investigation and management
• Investigation: rise in bilirubin following prolonged fasting or IV nicotinic acid
• No treatment required

263
Q

what does a hyperbilirubinaemia with normal dipsticks help to exclude (i.e. bilirubin not present)

A

Hyperbilirubinemia
Normal dipsticks urinalysis excludes Dubin-Johnson and Rotor syndrome as these both produce a conjugated bilirubinemia i.e. bilirubin in urine

264
Q

what is dubin-johnson syndrome?
-how is this inherited?
-what is this due to?

A

Dubin-Johnson syndrome is a benign autosomal recessive disorder resulting in hyperbilirubinemia (conjugated, therefore present in urine).
It is due to a defect in the canalicular multispecific organic anion transporter (cMOAT) protein.
This causes defective hepatic bilirubin excretion.

265
Q

Dubin-Johnson syndrome:
-elevation of liver enzymes?
-symptoms?
-liver biopsy?
-prognosis and treatment

A

Features:
• ↑ of conjugated
• NO elevation of liver enzymes (ALT, AST).
• Usually asymptomatic but may be diagnosed in early infancy based on laboratory tests.
• Liver biopsy shows dark granules in the hepatocytes (thought to be due to melanin deposition)
• Prognosis is good, and treatment of this syndrome is usually unnecessary. Most patients are
asymptomatic and have normal life spans.

266
Q

what is rotor syndrome:
-how is this inherited?
-common?

A

Rotor syndrome: is a rare, relatively benign autosomal recessive bilirubin disorder of unknown origin

267
Q

Describe the appearance of the liver in both dubin-johnson and rotor syndrome?

A

R - Normal
DJS - Liver has black pigmentation

268
Q

which syndrome, rotor or DJS, can the gallbladder be visualised by oral holecystogram?

A

rotor

269
Q

describe the urine coproporphyrins in rotor syndrome vs DJS

A

Rotor - ↑ with <70% being isomer 1
DJS - Normal with >80% being isomer 1

(Normal urine contains more of isomer 3 than isomer 1)

270
Q

what is crigler-najjar syndrome?
-what does this lead to?
-how many types exist?
-prognosis
-treatment

A

Crigler-Najjar Syndrome: (CNS) is a rare disorder affecting the metabolism of bilirubin, which results in high levels of unconjugated bilirubin and often leads to brain damage in infants.

This syndrome is divided type I and type II, with the latter sometimes called Arias syndrome.

Type I is usually fatal while only type II can survive to adult life. The syndrome is treated by liver transplantation.

271
Q

what are the five known hereditary defects in bilirubin metabolism

A

Gilberts syndrome
Rotor syndrome
DJS
Crigler-najjar type I
Crigler-najjar type 2

272
Q

bile acid malabsorption is a cause of diarrhoea, it can lead to steatorrhoea and vitamin A, D, E, K malabsorption:
-what are the three types?

A

• Type 1: Bile acid malabsorption, secondary to ileal resection, or ileal inflammation (e.g. in Crohn’s disease)

• Type 2: Idiopathic bile acid malabsorption, Primary bile acid diarrhea

• Type 3: Secondary to various gastrointestinal diseases including cholecystectomy, vagotomy,
small intestinal bacterial overgrowth, radiation enteropathy, celiac disease, chronic pancreatitis, etc.

273
Q

what tests are used to diagnose bile acid malabsorption?

A

• SeHCAT test (selenium homocholic acid taurine or tauroselcholic acid): nuclear test involves two scans a week apart and only very limited radiation exposure. Retention of SeHCAT at 7 days is normally above 15%. Values less than 15% predict a response to bile acid sequestrants. The SeHCAT test measures multiple cycles of bile acid excretion and reabsorption over 7 days. This test is not licensed in the USA, and is underutilized even where it is available
• Fecal bile acid quantfication or the 14C-glycocholic breath test are no longer in routine clinical use.

274
Q

what is the treatment for bile acid malabsorption?

A

Treatment with bile acid sequestrants is often effective e.g. cholestyramine.

275
Q

Hepatitis B:
-incubation period
-what type of virus
-how does this spread

A

• Incubation period (weeks) = 6-20
• Double-stranded DNA virus
• Spread: body fluids + vertical
• Chronic disease in 5-10%
• Vaccination available

276
Q

what does the hep B immunisation contain:
-what do most schedules do?

A

• Contains HBsAg adsorbed onto aluminum hydroxide adjuvant and is prepared from yeast cells using recombinant DNA technology
• Most schedules give 3 doses of the vaccine with a recommendation for a one-off booster 5 years following the initial primary vaccination

277
Q

who should be immunised for hep B?

A

• At risk groups who should be vaccinated include: healthcare workers, intravenous drug users, sex workers, close family contacts of an individual with hepatitis B, individuals receiving blood transfusions regularly, chronic kidney disease patients who may soon require renal replacement therapy, prisoners, chronic liver disease patients

278
Q

what percentage of adults fail to respond to 3 doses of hep B vaccine?
-what risk factors exist?

A

• Around 10-15% of adults fail to respond or respond poorly to 3 doses of the vaccine. Risk factors include age over 40 years, obesity, smoking, alcohol excess and immunosuppression

279
Q

Who should be tested for anti-HBs?

What should be done if the response is:
- >100
- 10-100
- <10

A

Testing for anti-HBs is only recommended for those at risk of occupational exposure (i.e.
Healthcare workers) and patients with chronic kidney disease. In these patients anti-HBs levels should be checked 1-4 months after primary immunization. The table below shows how to interpret anti-HBs levels:

Anti-HBs level (mIU/ml)
Response > 100
Indicates adequate response, no further testing required. Should still receive booster at 5 years

10 - 100
Suboptimal response - one additional vaccine dose should be given. If immunocompetent no further testing is required

< 10
Non-responder. Test for past or previous infection. Give further vaccine course (i.e. 3 doses again) with testing following. If still fails to respond then HBIG would be required for protection if exposed to the virus

280
Q

what are 7 complications of hep B?

A

• Chronic infection (5-10%)
• Fulminant liver failure (1%)
• Hepatocellular carcinoma
• GBS
• Glomerulonephritis (memberanoproliferative)
• Polyarteritis nodosa
• Cryoglobulinemia (more with Hepa C than Hepa B)

281
Q

what are the two treatments available for hep B
-how do either work
-what predicts a better response?

A

• Pegylated interferon-alpha used to be the only treatment available. It reduces viral replication in up to 30% of chronic carriers. A better response is predicted by being ♀ < 50 years old, low HBV DNA levels, non-Asian, HIV negative, high degree of inflammation on liver biopsy
• However due to the side-effects of pegylated interferon it is now used less commonly in clinical practice.

Oral antiviral medication is increasingly used with an aim to suppress viral replication (not in the dissimilar way to treating HIV patients)
• Examples include lamivudine, tenofovir and entecavir

282
Q

what is the treatment of Hep B based on?

A

Treatment of Hep B is based on:
• Abnormal ALT in at least 1 occasion
• Liver biopsy shows fibrosis
• Hepa B viremia >105 HBV DNA copies per mL

283
Q

serology Hep B Describe:
-HbsAG (surface antigen) when does this appear and what does this cause the production of?
-what does HBsAg imply if present from 1-6mth, if present for >6mths
-What does Anti-HBs imply
-What does Anti-HBc imply
-When does Anti-HBc appear and how long is it present for
-What is HBeAG? what is this a marker of?

A

• Surface antigen (HBsAg) is the first marker to appear and causes the production of anti-HBs
• HBsAg normally implies acute disease (present for 1-6 months)
• If HBsAg is present for > 6 months then this implies chronic disease
• Anti-HBs implies immunity (either exposure or immunization)
• Anti-HBc implies previous (or current) infection. IgM anti-HBc appears during acute or recent hepatitis B infection and is present for about 6 months (c=current or recent) Anti-HBc implies previous (or current) infection. IgG anti-HBc persists.
• HBeAg results from breakdown of core antigen from infected liver cells as is therefore a marker of infectivity (e=infectivity)

284
Q

what would the serology be in Previous immunization of Hep B

A

Anti-HBs positive, all others negative

285
Q

what would the serology be in Previous hepatitis B (> 6 months ago), not a carrier

A

anti-HBc positive, HBsAg negative

286
Q

what would the serology be in Previous hepatitis B, now a carrier

A

anti-HBc positive, HBsAg positive

287
Q

Hepatitis B in pregnancy:
-who is offered screening?
-what should babies recieve if they’ve been born to mothers who have chronic hep B infection
-does c-section reduce vertical transmission rate
-can this be transmitted through breast feeding

A

• All pregnant women are offered screening for hepatitis B
• Babies born to mothers who are chronically infected with hepatitis B or to mothers who’ve had
acute hepatitis B during pregnancy should receive a complete course of vaccination + hepatitis
B immunoglobulin
• Studies are currently evaluating the role of oral antiviral treatment (e.g. Lamivudine) in the
latter part of pregnancy
• There is little evidence to suggest caesarean section reduces vertical transmission rates
• Hepatitis B cannot be transmitted via breastfeeding (in contrast to HIV)

288
Q

Hepatitis C:
-who are at risk groups?
-what kind of virus is this?

A

Hepatitis C is likely to become a significant public health problem in the UK in the next decade. It is thought around 200,000 people are chronically infected with the virus. At risk groups include intravenous drug users and patients who received a blood transfusion prior to 1991 (e.g. hemophiliacs). Hepa C is an RNA virus.

289
Q

In Hep C what is the risk of transmission:
-needlestick
-sexual intercourse
-vertical transmission
-breastfeeding

A

Transmission
• Risk of transmission during a needle stick injury is about 2%
• The risk of transmitting the virus during sexual intercourse is probably less than 5%
• Vertical transmission rate from mother to child is about 6% (high viral load at delivery ↑ risk)
• Breast feeding is not contraindicated in mothers with Hepatitis C

290
Q

how many patients will develop acute hepatitis C after exposure?

A

Features
• After exposure to the Hepatitis C virus less than 20% of patients develop an acute hepatitis

291
Q

what are 4 complications of acute hepatitis C?

A

Complications
• Chronic infection (80-85%) - only 15-20% of patients will clear the virus and will hence the majority will develop chronic hepatitis C
• Cirrhosis (20-30% of those with chronic disease)
• Hepatocellular cancer
• Cryoglobulinemia

292
Q

what is the management of hep C?
which genotypes out of 2, 3, 3a and 4 will respond to tx?

A

• Currently a combination of interferon-α (S/C) and ribavirin (PO) are used
• Amantadine is a useful alternative for ribavirin and interferon in case if adverse effects.
• Genotype 2 and 3 respond to Rx while genotype 4 has less responsiveness.
• Genotype 3a on PCR is indication for chronic infection; it is more likely to respond to Rx

293
Q

what are the side effects of ribavirin?

A

Ribavirin - side-effects: hemolytic anemia, cough. Women should not become pregnant within 6 months of stopping ribavirin as it is teratogenic

294
Q

what are the side effect of interferon α?

A

Interferon α - side-effects: flu-like symptoms, depression, fatigue, leucopenia, thrombocytopenia

295
Q

who is autoimmune hepatitis most commonly seen in?

A

Autoimmune hepatitis is condition of unknown etiology which is most commonly seen in young ♀s.

296
Q

what are 4 assoc. of autoimmune hepatitis?

A

Recognized associations include other autoimmune disorders, hypergammaglobulinemia and HLA B8, DR3.

297
Q

How many types of autoimmune hepatitis have been characterised?

A

3

298
Q

Autoimmune hepatitis type 1:
-antibodies
-who does this affect?

A

anti-nuclear antib ANA
and/or
anti-smooth muscle antib SMA

Affects both adults and children

299
Q

Autoimmune hepatitis type 2:
-antibodies
-who does this affect?

A

Anti-liver/kidney microsomal type 1 antibodies (LKM1)

Affects children only

300
Q

Autoimmune hepatitis type 3:
-antibodies
-who does this affect?
-what percentage remits with steroid but then how many relapse, what is an alternative tx?

A

Soluble liver-kidney antigen

affects middle-aged adult

> 60% remission with steroids but relapse is 80%
Azathioprine is an alternative

301
Q

combination of deranged LFTs combined with secondary amenorrhea in a young female strongly suggest what?

A

autoimmune hepatitis

302
Q

what are the 4 features of autoimmune hepatitis?
-what is seen on liver biopsy?

A

• May present with signs of chronic liver disease
• Acute hepatitis: fever, jaundice etc (only 25% present in this way)
• Amenorrhea (common)
• ANA/SMA/LKM1 antibodies, raised IgG levels
• Liver biopsy: inflammation extending beyond limiting plate ‘piecemeal necrosis’, bridging
necrosis

303
Q

what is the management of autoimmune hepatitis?

A

Management
• Steroids, other immunosuppressants e.g. Azathioprine
• Liver transplantation

304
Q

when does alcoholic hepatitis occur?

A

Alcoholic Hepatitis: commonly occurs after a prolonged period of alcohol abuse or return to alcohol after period of abstinence

305
Q

Alcoholic hepatitis:
-ALT
-FBC
-AST/ALT
-acute phase reactants

A

Features:
• Increased serum transaminase
• Macrocytosis
• Thrombocytopenia
• Poor hepatic synthetic function
• Leucocytosis irrespective of infection
• Increased acute phase reactants.
• AST/ALT is usually > 2.
• Liver enzymes do not exceed 500.

306
Q

what features suggest poor prognosis in alc. hep.?

A

Malnutrition, jaundice, fluid retention and encephalopathy are associated with poor outlook

307
Q

what can be used in alc. hep to identify patients for treatment?

A

The discriminant function (DF) can be used to identify patients for treatment. Those who have DF > 32 have 1 month mortality rate of 50%, they may benefit from corticosteroids or pentoxyfilline. Histology can help to confirm diagnosis.
DF= 4.6 x (PT – control) + bilirubin (mg/dl)

308
Q

what is zieve’s syndrome?

A

Zieve’s Syndrome: occurs in patients with excessive alcohol consumption with hemolysis and severe hyperlipidemia, abdominal pain, transient mildly raised bilirubin. It usually occurs in males and resolves once alcohol consumption is stopped.

309
Q

what is NAFLD?
-common?
-describe the disease spectrum

A

Non-alcoholic fatty liver disease (NAFLD) is now the most common cause of liver disease in the developed world. It is largely caused by obesity and describes a spectrum of disease ranging from:
• Steatosis - fat in the liver
• Steatohepatitis - fat with inflammation, non-alcoholic steatohepatitis (NASH), see below
• Progressive disease may cause fibrosis and liver cirrhosis

310
Q

what is thought t be a key mechanism in NAFLD leading to steatosis?

A

NAFLD is thought to represent the hepatic manifestation of the metabolic syndrome and hence insulin resistance is thought to be the key mechanism leading to steatosis

311
Q

what is NASH

A

Non-alcoholic steatohepatitis (NASH) is a term used to describe liver changes similar to those seen in alcoholic hepatitis in the absence of a history of alcohol abuse. It is relatively common and though to affect around 3-4% of the general population. The progression of disease in patients with NASH may be responsible for a proportion of patients previously labeled as cryptogenic cirrhosis.

312
Q

what should Obese T2DM with abnormal LFTs make you think?

A

NAFLD

313
Q

what are assoc. features of NAFLD?

A

Associated factors
• Obesity
• Hyperlipidemia
• T2DM
• Jejunoileal bypass
• Sudden weight loss/starvation

314
Q

what are the features found in NAFLD:
-symptoms
-examination
-ALT/AST
-USS findings

A

Features
• Usually asymptomatic
• Hepatomegaly
• ALT is typically greater than AST
• Increased echogenicity on ultrasound

315
Q

What is the management of NAFLD

A

• The mainstay of treatment is lifestyle changes (particularly weight loss) and monitoring
• There is ongoing research into the role of gastric banding and insulin-sensitizing drugs (e.g.
Metformin

316
Q

what is micronodular liver cirrhosis assoc with?

A

Micronodular cirrhosis is associated with alcohol liver disease

317
Q

what is macronodular liver cirrhosis assoc with?

A

Macronodular cirrhosis is associated with chronic hepatitis

318
Q

is granuloma formation classically seen in liver cirrhosis?

A

Granuloma formation is not classically seen in cirrhosis.

319
Q

what is the classification system for liver cirrhosis?

A

The Child-Pugh classification is a scoring system to assess the severity of liver cirrhosis

Bilirubin (μmol/l)
Normal: 5-17
1: <34
2: 34-50
3: >50

Albumin (g/l)
N: 36-52
1: >35
2: 28-35
3: <28

Prothrombin time, prolonged by (s)
N: 12-15
1: <4
2: 4-6
3: >6

Encephalopathy
1: none
2: mild
3: marked

Ascites
1: none
2: mild
3: marked

• <7 = A
• 7-9 = B
• >9 =C

320
Q

Hepatocellular ca:
-common
-what is most common cause of this in the UK
-what is the most common cause of this in europe?

A

Hepatocellular carcinoma (HCC) is the third most common cause of cancer worldwide. Chronic hepatitis B is the most common cause of HCC worldwide with chronic hepatitis C being the most common cause in Europe.

321
Q

what are the risk factors for hepatocellular ca:
-main risk factor
-others

A

The main risk factor for developing HCC is liver cirrhosis, for example secondary* to hepatitis B & C, alcohol, hemochromatosis and primary biliary cirrhosis.
Other risk factors include:
• Alpha-1 antitrypsin deficiency
• Hereditary tyrosinosis
• Glycogen storage disease
• Aflatoxin
• Drugs: oral contraceptive pill, anabolic steroids
• Porphyria cutanea tarda
• ♂ sex
• Diabetes mellitus, metabolic syndrome

*Wilson’s disease is an exception

322
Q

what are the features of hepatocellular ca:
-presentation

A

Features
• Tends to present late
• Features of liver cirrhosis or failure may be seen: jaundice, ascites, RUQ pain, hepatomegaly,
pruritus, splenomegaly
• Possible presentation is decompensation in a patient with chronic liver disease

323
Q

what is the screening for hepatocellular ca?

A

Screening with ultrasound (+/- alpha-fetoprotein) should be considered for high risk groups such as:
• Patients liver cirrhosis secondary to hepatitis B & C or hemochromatosis
• Men with liver cirrhosis secondary to alcohol

324
Q

what are the management options for hepatocellular ca?

A

Management options
• Early disease: surgical resection
• Liver transplantation
• Radiofrequency ablation
• Transarterial chemoembolisation
• Sorafenib: a multikinase inhibitor

325
Q

what are 8 contraindications to liver biopsy?

A

• Deranged clotting (e.g. INR > 1.4)
• Low platelets (e.g. < 60 * 109/l)
• Anemia
• Bile duct obstruction
• Hydatid cyst
• Hemoangioma
• Uncooperative patient
• Ascites

326
Q

what is the management of a pyogenic liver abscess?

A

Management
• Drainage (needle aspiration or catheter) should always be performed
• Amoxicillin + ciprofloxacin + metronidazole
• If penicillin allergic: ciprofloxacin + clindamycin

327
Q

what is hepatorenal syndrome?

A

Hepatorenal Syndrome (HRS): refers to the development of acute renal failure in a patient who has advanced liver disease, who has no identifiable cause of intrinsic renal disease. It usually represents the end-stage of a sequence of reductions in renal perfusion induced by increasingly severe hepatic injury. Splanchnic vasodilatation appears to play an important role in the decline in renal function in hepatic disease.

328
Q

what is the diagnostic criteria for hepatorenal syndrome?

A

Diagnostic criteria have been proposed for the hepatorenal syndrome:
1. Chronic or acute hepatic disease with advanced hepatic failure and portal hypertension
2. Creatinine > 133 mmol/l that progresses over days to weeks
3. Absence of any other apparent cause for the renal disease, including shock, active sepsis,
current nephrotoxic drugs, and the absence of ultrasonographic evidence of obstruction or parenchymal renal disease. It is particularly important to exclude spontaneous bacterial peritonitis, which is complicated with acute renal failure
4. Urine sodium < 10 meq/l (off diuretics) and protein excretion < 500 mg/day
5. Lack of improvement in renal function after volume expansion with 1.5litres of isotonic saline.

329
Q

how many type of hepatorenal syndrome exist and describe them

A

Type 1:
• Rapidly progressive
• Doubling of serum creatinine to > 221 μmol/L or a halving of the creatinine clearance to less than 20 ml/min over a period of less than 2 weeks
• Very poor prognosis

Type 2:
•Slowly progressive •Prognosis poor, but patients may live for longer

330
Q

what is the management of hepatorenal syndrome?

A

Management: is notoriously difficult. The ideal treatment is liver transplantation but patients are often too unwell to have surgery and there is a shortage of donors. Management options:
• Vasopressin analogues, for example terlipressin, have a growing evidence base supporting their use. They work by causing vasoconstriction of the splanchnic circulation
• Volume expansion with 20% albumin
• Transjugular intrahepatic portosystemic shunt

331
Q

Anal fissures:
-what are these
-when are they defined as acute vs chronic
-where do these occur

A

Anal fissures are longitudinal or elliptical tears of the squamous lining of the distal anal canal. If present for less than 6 weeks they are defined as acute, and chronic if present for more than 6 weeks. Around 90% of anal fissures occur on the posterior midline

332
Q

describe the management of an acute anal fissure?

A

Management of an acute anal fissure (< 6 weeks)
• Dietary advice: high-fiber diet with high fluid intake
• Bulk-forming laxatives are first line - if not tolerated then lactulose should be tried
• Lubricants such as petroleum jelly may be tried before defecation
• Topical anesthetics
• Sits baths: hip baths in hot water for 2–5 minutes followed by cold water for 1 minute
• Topical steroids do not provide significant relief

333
Q

what is the management of a chronic anal fissure

A

Management of a chronic anal fissure (> 6 weeks)
• The above techniques should be continued
• Topical glyceryl trinitrate (GTN) is first line treatment for a chronic anal fissure
• If topical GTN is not effective after 8 weeks then secondary referral should be considered for
surgery or botulinum toxin

334
Q

what is mesenteric ischaemia primarily caused by?
-where is it most likely to occur?

A

Mesenteric ischemia is primarily caused by arterial embolism resulting in infarction of the colon. It is more likely to occur in areas such as the splenic flexure that are located at the borders of the territory supplied by the superior and inferior mesenteric arteries.

335
Q

what are the predisposing factors of mesenteric ischaemia?

A

Predisposing factors
• Increasing age
• Atrial fibrillation
• Other causes of emboli: endocarditis
• Cardiovascular disease risk factors: smoking, hypertension, diabetes

336
Q

what are the features of mesenteric ischaemia?
-what do bloods typically show?

A

Features
• Abdominal pain
• Rectal bleeding
• Diarrhea
• Fever
• Bloods typically show an elevated WBC associated with acidosis (low HCO3)

337
Q

what does meckels diverticulum present with? how is this diagnosed?

A

Meckel’s Diverticulum:
• Presents with intermittent melena and anemia
• Diagnosed with Meckel’s Scan [Technetium-99m (99mTc)] or Video Capsule Endoscopy

338
Q

what is the management of meckels diverticulum?

A

Management
• Mesenteric angiography is the diagnostic tool
• Supportive care
• Laparotomy and bowel resection

339
Q

what is the most common form of bowel ischaemia:
-who does this present in?
-what are the causes of this?

A

Ischemic Colitis: Although uncommon in the general population, ischemic colitis occurs with greater frequency in the elderly, and is the most common form of bowel ischemia. Causes of the reduced blood flow can include ↓BP or local factors such as constriction of blood vessels or atheroma in the mesenteric vessels (most common).

340
Q

bowel ischaemia:
-what is seen on barium enema?
-what is the single best test after plain radiography?
-what is the diagnostic tool of choice and what is found on this?

A

Diagnosis:
• Barium enema results tend to be
abnormal in 90% showing thumbprinting,
an indicative of mucosal edema
• CT is the single best test after plain
radiography
• Colonoscopy is the diagnostic tool of
choice: it shows petechiae, pallor, hyperemia and necrosis

341
Q

what is the most common presenting feature of retroperitoneal fibrosis?

A

Lower back pain is the most common presenting feature

342
Q

what are 5 assoc with Retropritoneal Fibrosis:

A

Associations
• Riedel’s thyroiditis
• Previous radiotherapy
• Sarcoidosis
• Inflammatory abdominal aortic aneurysm
• Drugs: methysergide

343
Q

describe what co-infection vs superinfection of hep D means?

A

Hepatitis D terminology:

Co-infection: Hepatitis B and Hepatitis D infection at the same time.
Superinfection: A hepatitis B surface antigen positive patient subsequently develops a hepatitis D infection.
344
Q

How to treat proctitis in UC?

A

proctitis

topical (rectal) aminosalicylate: for distal colitis rectal mesalazine has been shown to be superior to rectal steroids and oral aminosalicylates
if remission is not achieved within 4 weeks, add an oral aminosalicylate
if remission still not achieved add topical or oral corticosteroid
345
Q

how to treat protosigmoiditis and left-sided UC?

A

proctosigmoiditis and left-sided ulcerative colitis

topical (rectal) aminosalicylate
if remission is not achieved within 4 weeks, add a high-dose oral aminosalicylate OR switch to a high-dose oral aminosalicylate and a topical corticosteroid
if remission still not achieved stop topical treatments and offer an oral aminosalicylate and an oral corticosteroid
346
Q

how to treat extensive disease in UC

A

extensive disease

topical (rectal) aminosalicylate and a high-dose oral aminosalicylate:
if remission is not achieved within 4 weeks, stop topical treatments and offer a high-dose oral aminosalicylate and an oral corticosteroid
347
Q

when should a patient be considered for bariatric surgery?

A

they have a BMI of 40 kg/m^2 or more, or between 35 kg/m^2 and 40 kg/m^2 and other significant disease (for example, type 2 diabetes mellitus, hypertension) that could be improved if they lost weight
all appropriate non-surgical measures have failed to achieve or maintain adequate clinically beneficial weight loss for at least 6 months
they are receiving or will receive intensive specialist management
they are generally fit for anaesthesia and surgery
they commit to the need for long-term follow-up

Consider surgery as a first-line option for adults with a BMI of more than 50 kg/m2 in whom surgical intervention is considered appropriate; consider orlistat before surgery if the waiting time is long

348
Q

what three bariatric operations exist?

A

primarily restrictive: laparoscopic-adjustable gastric banding (LAGB) or sleeve gastrectomy

primarily malabsorptive: classic biliopancreatic diversion (BPD) has now largely been replaced by
biliopancreatic diversion with duodenal switch

mixed: Roux-en-Y gastric bypass surgery

349
Q

when to consider a LAGB in bariatric surgery?

A

LAGB produces less weight loss than malabsorptive or mixed procedures but as it has fewer complications it is normally the first-line intervention in patients with a BMI of 30-39kg/m^2

350
Q

when is a gastric bypass or sleeve gastrectomy considered for patients?

A

patients with a BMI > 40 kg/m^2 may be considered for a gastric bypass or sleeve gastrectomy. The latter may be done as a sole procedure or as an initial procedure prior to bypass

351
Q

when would malabsorptive surgical procedure i.e. BPD be considered in bariatric surgery?

A

primarily malabsorptive procedures are usually reserved for very obese patients (e.g. BMI > 60 kg/m^2)

352
Q

what are the features of hepatic encephalopathy?

A

confusion, altered GCS (see below)
asterix: ‘liver flap’, arrhythmic negative myoclonus with a frequency of 3-5 Hz
constructional apraxia: inability to draw a 5-pointed star
triphasic slow waves on EEG
raised ammonia level (not commonly measured anymore)

353
Q

describe the grading of hepatic encephalopathy?

A

Grade I: Irritability
Grade II: Confusion, inappropriate behaviour
Grade III: Incoherent, restless
Grade IV: Coma

354
Q

list 8 precipitants for hepatic encephalopathy

A

infection e.g. spontaneous bacterial peritonitis
GI bleed
post transjugular intrahepatic portosystemic shunt
constipation
drugs: sedatives, diuretics
hypokalaemia
renal failure
increased dietary protein (uncommon)

355
Q

what is the treatment for hepatic encephalopathy

A

treat any underlying precipitating cause
NICE recommend lactulose first-line, with the addition of rifaximin for the secondary prophylaxis of hepatic encephalopathy
lactulose is thought to work by promoting the excretion of ammonia and increasing the metabolism of ammonia by gut bacteria
antibiotics such as rifaximin are thought to modulate the gut flora resulting in decreased ammonia production
other options include embolisation of portosystemic shunts and liver transplantation in selected patients

356
Q

what are the metabolic consequences of refeeding syndrome?

A

hypophosphataemia
hypokalaemia
hypomagnesaemia: may predispose to torsades de pointes
abnormal fluid balance

357
Q

what are 4 factors that deem someone high risk for refeeding syndrome?

A

Patients are considered high-risk if one or more of the following:
BMI < 16 kg/m2
unintentional weight loss >15% over 3-6 months
little nutritional intake > 10 days
hypokalaemia, hypophosphataemia or hypomagnesaemia prior to feeding (unless high)

or 2 or more of the following
BMI < 18.5 kg/m2
unintentional weight loss > 10% over 3-6 months
little nutritional intake > 5 days
history of: alcohol abuse, drug therapy including insulin, chemotherapy, diuretics and antacids

358
Q

how to manage someone with potential refeeding syndrome risk

A

NICE recommend that if a patient hasn’t eaten for > 5 days, aim to re-feed at no more than 50% of requirements for the first 2 days.

359
Q

what drugs cause a hepatocellular drug induced liver disease

A

paracetamol
sodium valproate, phenytoin
MAOIs
halothane
anti-tuberculosis: isoniazid, rifampicin, pyrazinamide
statins
alcohol
amiodarone
methyldopa
nitrofurantoin

360
Q

what drugs cause a cholestatic drug induced liver disease?

A

combined oral contraceptive pill
antibiotics: flucloxacillin, co-amoxiclav, erythromycin*
anabolic steroids, testosterones
phenothiazines: chlorpromazine, prochlorperazine
sulphonylureas
fibrates
rare reported causes: nifedipine

361
Q

what three drugs cause liver cirrhosis?

A

methotrexate
methyldopa
amiodarone

362
Q

what is the most common liver disease in pregnancy?
-when does this occur?

A

Intrahepatic cholestasis of pregnancy (also known as obstetric cholestasis) occurs in around 1% of pregnancies and is generally seen in the third trimester. It is the most common liver disease of pregnancy.

363
Q

what are the features of intrahepatic cholestasis of pregnancy?

A

Features

pruritus, often in the palms and soles
no rash (although skin changes may be seen due to scratching)
raised bilirubin
364
Q

what is the management of intrahepatic cholestasis of pregnancy?

A

Management

ursodeoxycholic acid is used for symptomatic relief
weekly liver function tests
women are typically induced at 37 weeks
365
Q

what are the complications of intrahepatic cholestasis of pregnancy?

A

Complications include an increased rate of stillbirth. It is not generally associated with increased maternal morbidity

366
Q

How common is acute fatty liver of pregnancy and when may this occur?

A

Acute fatty liver of pregnancy is rare complication which may occur in the third trimester or the period immediately following delivery.

367
Q

what are the features of acute fatty liver of pregnancy?

A

Features

abdominal pain
nausea & vomiting
headache
jaundice
hypoglycaemia
severe disease may result in pre-eclampsia
368
Q

what is typically elevated in acute fatty liver disease of pregnancy?

A

Investigations

ALT is typically elevated e.g. 500 u/l
369
Q

what is the manageement of acute fatty liver disease of pregnancy?

A

Management

support care
once stabilised delivery is the definitive managemen
370
Q

what is the triad of budd-chiari syndrome?

A

Budd-Chiari syndrome - a triad of abdominal pain, hepatomegaly and ascites. It is occlusion of the hepatic veins that drain the liver that causes a painful distension of the liver capsule and backflow portal hypertension - which will lead to the ascites.

371
Q

what investigation is used for budd chiari?

A

ultrasound with Doppler flow studies is very sensitive and should be the initial radiological investigation

372
Q

what is charcots triad? and what is this assoc. with?

A

Charcot’s triad (right upper quadrant pain, fever and jaundice), which is classically linked to ascending cholangitis.

373
Q

what is the most common organism found in SBP?

A

e coli

374
Q

what is the management and prophylaxis of SBP?

A

Management

intravenous cefotaxime is usually given

Antibiotic prophylaxis should be given to patients with ascites if:

patients who have had an episode of SBP
patients with fluid protein <15 g/l and either Child-Pugh score of at least 9 or hepatorenal syndrome
NICE recommend: 'Offer prophylactic oral ciprofloxacin or norfloxacin for people with cirrhosis and ascites with an ascitic protein of 15 g/litre or less until the ascites has resolved'
375
Q

what should diarrhoea and hypokalaemia prompt a diagnosis of?
what is this?
what are the features?

A

Diarrhoea + hypokalaemia → villous adenoma

Villous adenomas are colonic polyps with the potential for malignant transformation. They characteristically secrete large amounts of mucous, potentially resulting in electrolyte disturbances.

The vast majority are asymptomatic. Possible features:

non-specific lower gastrointestinal symptoms
secretory diarrhoea may occur
microcytic anaemia
hypokalaemia
376
Q

what is Plummer-Vinson syndrome?

A

Triad of:

dysphagia (secondary to oesophageal webs)
glossitis
iron-deficiency anaemia

Treatment includes iron supplementation and dilation of the webs

377
Q

what are typical symptoms for haemochromatosis?

A

This patient has typical symptoms of haemochromatosis:

lethargy
arthralgia, with evidence of chrondrocalcinosis
diabetes mellitus (polyuria and polydipsia)
378
Q

How long do you have to wait to fly
10 days/48 hours/24hours after
• following abdominal surgery
• Laparoscopic surgery
• Colonoscopy
• Following the application of a plaster cast

A

• Travel should be avoided for 10 days following abdominal surgery
• Laparoscopic surgery: after 24 hours
• Colonoscopy: after 24 hours
• Following the application of a plaster cast, the majority of airlines restrict flying for 24 hours on
flights of less than 2 hours or 48 hours for longer flights

379
Q

what is reye’s syndrome?

A

Reye’s syndrome: is a severe, progressive encephalopathy affecting children that is accompanied by fatty infiltration of the liver, kidneys and pancreas. The aetiology of Reye’s syndrome is not fully understood although there is a known association with aspirin use and a viral cause has been postulated.

380
Q

what are the features of reyes syndrome?

A

The peak incidence is 2 years of age, features include:
• May be history of preceding viral illness
• Encephalopathy: confusion, seizures, cerebral oedema, coma
• Fatty infiltration of the liver, kidneys and pancreas
• Hypoglycaemia

381
Q

what is the management of reyes syndrome?

A

Management is supportive
Prognosis is poor - 30-40% mortality

382
Q

• Crohn’s, to a lesser extent UC
• Cirrhosis, primary biliary cirrhosis
• Graves’ disease (thyroid acropachy)
• Rare: Whipple’s disease
are all causes of…

A

clubbing